syndrome	score	normalized_score
ODONTOONYCHODERMAL DYSPLASIA; OODD	1.0142857	100.0
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	1.00185874	98.77480674330714
TRICHOHEPATOENTERIC SYNDROME 1	0.51470567	50.7456301513469
IMMUNODEFICIENCY 36; IMD36	0.5	49.29577534219401
DYSTONIA 6, TORSION	0.25	24.647887671097006
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	24.647887671097006
HYPERPARATHYROIDISM 2	0.25	24.647887671097006
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	24.647887671097006
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.22118081	21.806559039529
MACS SYNDROME	0.13893926999999998	13.698238080256871
VAN MALDERGEM SYNDROME 2; VMLDS2	0.1332884	13.141110044240985
VAN MALDERGEM SYNDROME 1; VMLDS1	0.1332884	13.141110044240985
#616006 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2	0.12965204	12.782595672994304
MARSHALL-SMITH SYNDROME; MRSHSS	0.1277933	12.599339614075205
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.125	12.323943835548503
ECTODERMAL DYSPLASIA 8, HAIR/TOOTH/NAIL TYPE	0.125	12.323943835548503
KLEEFSTRA SYNDROME	0.10630223	10.480501696908473
FRONTOMETAPHYSEAL DYSPLASIA	0.09981717000000001	9.841129575227177
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.09556896000000001	9.422291963694253
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.0937024	9.2382649188488
HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.09276784	9.1461251992412
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.0909091	8.9628691403221
COFFIN-SIRIS SYNDROME 10; CSS10	0.0909091	8.9628691403221
PYCNODYSOSTOSIS	0.0909091	8.9628691403221
DENTAL NONERUPTION	0.0909091	8.9628691403221
#259710 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2;;OSTEOPETROSIS, OSTEOCLAST-POOR;;OSTEOPETROSIS, MILD AUTOSOMAL RECESSIVE FORM	0.0909091	8.9628691403221
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.08191421	8.076048986986605
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.07912091	7.800653208459904
15q26 overgrowth syndrome	0.07847793	7.737260813200857
BARDET-BIEDL SYNDROME 1; BBS1	0.07727068000000001	7.618236163637129
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.07692370000000001	7.584026867380661
FUMARASE DEFICIENCY; FMRD	0.07328734	7.2255124961339785
HISTIDINEMIA	0.07142860000000001	7.04225643721488
BETA-UREIDOPROPIONASE DEFICIENCY	0.07142860000000001	7.04225643721488
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.07142860000000001	7.04225643721488
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.07142860000000001	7.04225643721488
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.07142860000000001	7.04225643721488
DYSLEXIA, SUSCEPTIBILITY TO, 1	0.07142860000000001	7.04225643721488
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.07142860000000001	7.04225643721488
ALZHEIMER DISEASE 10	0.07142860000000001	7.04225643721488
ABLEPHARON-MACROSTOMIA SYNDROME	0.06267152	6.178882340547638
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.05611465	5.532430359611695
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.05434443	5.357901624759178
MEHMO SYNDROME; MEHMO	0.05354221	5.278809510969148
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.05108952	5.036995000521056
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.049486260000000004	4.878927110970804
OROFACIODIGITAL SYNDROME XIV; OFD14	0.04782625	4.715264150919213
Myhre syndrome	0.04745316	4.678480629274375
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.04745316	4.678480629274375
JOUBERT SYNDROME 26	0.047453159999999994	4.678480629274374
SHPRINTZEN OMPHALOCELE SYNDROME	0.04711466	4.64510738936771
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.046891270000000006	4.623083022860325
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.0462716	4.5619887966477295
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.0458499	4.520412739724123
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.0458499	4.520412739724123
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.0458499	4.520412739724123
HEART AND BRAIN MALFORMATION SYNDROME	0.045495100000000004	4.485432457541302
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.04527171	4.463408091033917
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0450584	4.442377527357429
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.04465986	4.403084850747674
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.04465986	4.403084850747674
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.04465986	4.403084850747674
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.04363636	4.302176398622202
PSEUDOXANTHOMA ELASTICUM; PXE	0.043478300000000004	4.286593018121029
#148500 TYLOSIS WITH ESOPHAGEAL CANCER; TOC;;KERATOSIS PALMARIS ET PLANTARIS WITH ESOPHAGEAL CANCER	0.043478300000000004	4.286593018121029
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.043478300000000004	4.286593018121029
BLEPHAROCHALASIS AND DOUBLE LIP	0.043478300000000004	4.286593018121029
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	4.286593018121029
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.043478300000000004	4.286593018121029
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.043478300000000004	4.286593018121029
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.043478300000000004	4.286593018121029
MAL DE MELEDA	0.043478300000000004	4.286593018121029
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.043478300000000004	4.286593018121029
CYCLIC NEUTROPENIA	0.043478300000000004	4.286593018121029
BAZEX SYNDROME; BZX	0.043478300000000004	4.286593018121029
LIP, HAMARTOMATOUS	0.043478300000000004	4.286593018121029
LIP, MEDIAN NODULE OF UPPER	0.043478300000000004	4.286593018121029
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.043478300000000004	4.286593018121029
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.043478300000000004	4.286593018121029
#275350 TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY	0.043478300000000004	4.286593018121029
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.043478300000000004	4.286593018121029
HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	0.04280112	4.219828791828574
HOLOPROSENCEPHALY 3; HPE3	0.04280112	4.219828791828574
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.04280112	4.219828791828574
HOLOPROSENCEPHALY 11	0.04280112	4.219828791828574
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.04280112	4.219828791828574
CHROMOSOME 15Q14 DELETION SYNDROME	0.04280112	4.219828791828574
OROFACIAL CLEFT 11; OFC11	0.04	3.943662027375521
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	0.04	3.943662027375521
KOOLEN-DE VRIES SYNDROME; KDVS	0.034833699999999995	3.4343084990747665
SPEECH-LANGUAGE DISORDER 1	0.03335178	3.2882037082845588
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.033096299999999995	3.263015538915711
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.033096299999999995	3.263015538915711
WITTEVEEN-KOLK SYNDROME	0.0321512	3.169836664363896
PHELAN-MCDERMID SYNDROME; PHMDS	0.03186885	3.141999340028159
WIEDEMANN-STEINER SYNDROME; WDSTS	0.03155396	3.1109538466331523
ZTTK SYNDROME; ZTTKS	0.03146399	3.102083564818078
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.03065408	3.0222332820032856
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.030406419999999997	2.9978160985607896
CYANIDE, INABILITY TO SMELL	0.030302999999999997	2.98761976038901
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.030302999999999997	2.98761976038901
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.030302999999999997	2.98761976038901
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.030302999999999997	2.98761976038901
WAARDENBURG SYNDROME, TYPE IIB	0.030302999999999997	2.98761976038901
OROFACIAL CLEFT 3	0.030302999999999997	2.98761976038901
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.030302999999999997	2.98761976038901
22q11.2 distal deletion syndrome	0.030302999999999997	2.98761976038901
DWARFISM, LEVI TYPE	0.030302999999999997	2.98761976038901
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.030302999999999997	2.98761976038901
CLEFT CHIN	0.030302999999999997	2.98761976038901
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.030302999999999997	2.98761976038901
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.030302999999999997	2.98761976038901
Growth hormone deficiency, isolated, type IA	0.030302999999999997	2.98761976038901
OSTEOPENIA AND SPARSE HAIR	0.030302999999999997	2.98761976038901
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.030302999999999997	2.98761976038901
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.030302999999999997	2.98761976038901
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.030302999999999997	2.98761976038901
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.030302999999999997	2.98761976038901
15q13.3 microdeletion syndrome	0.030302999999999997	2.98761976038901
DIMPLES, FACIAL	0.030302999999999997	2.98761976038901
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.030302999999999997	2.98761976038901
NASAL BONES, ABSENCE OF	0.030302999999999997	2.98761976038901
15q24 recurrent microdeletion syndrome	0.030302999999999997	2.98761976038901
NASAL GROOVE, FAMILIAL TRANSVERSE	0.030302999999999997	2.98761976038901
EDINBURGH MALFORMATION SYNDROME	0.030302999999999997	2.98761976038901
NASAL ALAR COLLAPSE, BILATERAL	0.030302999999999997	2.98761976038901
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.030302999999999997	2.98761976038901
MENKES DISEASE	0.030302999999999997	2.98761976038901
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.030302999999999997	2.98761976038901
AYME-GRIPP SYNDROME; AYGRP	0.026399469999999994	2.602764684545981
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.025305380000000002	2.4948966548576994
OROFACIODIGITAL SYNDROME I; OFD1	0.025028789999999995	2.4676272178539036
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.024812	2.446253555581036
190360 TRICHODYSPLASIA-XERODERMA	0.024812	2.446253555581036
GAPO SYNDROME; GAPOS	0.024289839999999997	2.3947729914756755
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.02428492	2.394287921046309
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.024184359999999995	2.384373554709486
KABUKI SYNDROME 1	0.023928879999999993	2.359185385340638
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.02383123	2.3495579204163084
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	0.02371966	2.3385580611064514
CRANIOFRONTONASAL SYNDROME; CFNS	0.02361399	2.328139891945632
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.02347228	2.3141684832981477
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.02301008	2.268599468571823
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.022763109999999996	2.2442503132993
CRI-DU-CHAT SYNDROME	0.022442459999999997	2.2126369325723507
HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.022431099999999995	2.211516932556576
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.022431099999999995	2.211516932556576
ALSTROM SYNDROME; ALMS	0.022431099999999995	2.211516932556576
BRANCHIOOCULOFACIAL SYNDROME	0.02215126	2.183927073013057
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.02197801	2.166846086856987
PHENYLKETONURIA	0.02197801	2.166846086856987
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.021935999999999997	2.1627042558127356
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.021935999999999997	2.1627042558127356
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.021818999999999998	2.1511690443826623
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0216612	2.1356112976846657
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0216612	2.1356112976846657
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.02161354	2.1309124243790483
RETT SYNDROME; RTT	0.02161354	2.1309124243790483
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.021575129999999998	2.1271255229172605
SMITH-MAGENIS SYNDROME; SMS	0.021383239999999998	2.108206790256433
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.02133876	2.1038214380819915
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.020715360000000002	2.0423594653853447
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.020449830000000002	2.016180450932119
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.020449830000000002	2.016180450932119
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.020448679999999997	2.0160670706488313
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.020448679999999997	2.0160670706488313
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.020328290000000002	2.0041976338619385
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.019919569999999998	1.9639012952662152
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.019723229999999998	1.9445438302048423
CHROMOSOME 10Q26 DELETION SYNDROME	0.01964916	1.9372411540456498
TONNE-KALSCHEUER SYNDROME; TOKAS	0.01964916	1.9372411540456498
#611554 LEOPARD SYNDROME 2	0.01955741	1.9281953792703574
MOWAT-WILSON SYNDROME; MOWS	0.01952762	1.9252583369754692
COFFIN-SIRIS SYNDROME 1; CSS1	0.019492999999999996	1.9218450974907757
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.01931083	1.9038846747026008
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.0191427	1.8873084772860347
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.0191427	1.8873084772860347
OGDEN SYNDROME; OGDNS	0.01895413	1.8687170685734797
BARBER-SAY SYNDROME; BBRSAY	0.01893774	1.8671011530577628
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.01893774	1.8671011530577628
TRANSSEXUALITY	0.0188679	1.860215519157965
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	1.860215519157965
ANDROSTENONE, ABILITY TO SMELL	0.0188679	1.860215519157965
JUMPING FRENCHMAN OF MAINE	0.0188679	1.860215519157965
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0188679	1.860215519157965
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	1.860215519157965
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	1.860215519157965
ALCOHOL DEPENDENCE	0.0188679	1.860215519157965
SPASTIC PSEUDOSCLEROSIS	0.0188679	1.860215519157965
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	1.860215519157965
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	1.860215519157965
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	1.860215519157965
MOTION SICKNESS	0.0188679	1.860215519157965
269800 SENILE PLAQUE FORMATION	0.0188679	1.860215519157965
RHEUMATOID ARTHRITIS	0.0188679	1.860215519157965
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	1.860215519157965
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	1.860215519157965
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	1.860215519157965
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	1.860215519157965
CERVICAL RIB	0.0188679	1.860215519157965
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	1.860215519157965
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	1.860215519157965
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	1.860215519157965
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	1.860215519157965
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	1.860215519157965
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	1.860215519157965
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	1.860215519157965
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	1.860215519157965
PALMOMENTAL REFLEX	0.0188679	1.860215519157965
THUMBS, CONGENITAL CLASPED	0.0188679	1.860215519157965
MYOPATHY, CONGENITAL	0.0188679	1.860215519157965
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	1.860215519157965
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	1.860215519157965
DIASTEMATOMYELIA	0.0188679	1.860215519157965
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	1.860215519157965
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	1.860215519157965
CARDIAC ARRHYTHMIA	0.0188679	1.860215519157965
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	1.860215519157965
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	1.860215519157965
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	1.860215519157965
ERYTHERMALGIA, PRIMARY	0.0188679	1.860215519157965
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	1.860215519157965
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	1.860215519157965
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0188679	1.860215519157965
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	1.860215519157965
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	1.860215519157965
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	1.860215519157965
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0188679	1.860215519157965
ENDOCARDIAL FIBROELASTOSIS	0.0188679	1.860215519157965
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.01858994	1.8328110117297323
GABRIELE-DE VRIES SYNDROME; GADEVS	0.01836655	1.8107866452223467
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.01811107	1.7855984758534997
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.01792206	1.7669636868586434
CORNELIA DE LANGE SYNDROME 3	0.01782168	1.7570670670009443
SCLEROSTEOSIS 1; SOST1	0.01772236	1.7472749541869712
HALLERMANN-STREIFF SYNDROME; HSS	0.01769867	1.744939320351258
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.01755127	1.7304069257803791
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.01752717	1.7280308694088857
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.01752717	1.7280308694088857
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.01752717	1.7280308694088857
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.01740105	1.7155965030365705
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.017399899999999996	1.7154831227532827
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.017399899999999996	1.7154831227532827
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.01733448	1.7090332635075107
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.01733448	1.7090332635075107
3MC SYNDROME 2	0.01729579	1.7052187564115313
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.01717651	1.6934587562458976
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.017134780000000002	1.6893445308358388
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.01712627	1.6885055167395142
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.01712627	1.6885055167395142
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.01712627	1.6885055167395142
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.01708682	1.684616080065015
XFE PROGEROID SYNDROME; XFEPS	0.017079	1.6838450941386633
POPOV-CHANG SYNDROME; POPCHAS	0.017079	1.6838450941386633
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.017079	1.6838450941386633
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.016963779999999998	1.6724853756688078
DEAFNESS-CRANIOFACIAL SYNDROME	0.01695596	1.6717143897424558
GLASS SYNDROME	0.01695518	1.6716374883329221
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.01692993	1.6691480516781414
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.01692993	1.6691480516781414
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.01692993	1.6691480516781414
MOEBIUS SYNDROME; MBS	0.01681232	1.6575526994021503
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.01673257	1.6496900232350706
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.016726500000000002	1.6490915725224167
PRIMROSE SYNDROME; PRIMS	0.01669188	1.645678333037723
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.016600379999999998	1.6366572061501012
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.01659261	1.6358911498012836
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.01659261	1.6358911498012836
OROFACIODIGITAL SYNDROME IX; OFD9	0.01656466	1.633135515959655
RECOMBINANT CHROMOSOME 8 SYNDROME	0.016556839999999996	1.6323645300333027
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.016556839999999996	1.6323645300333027
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.01636231	1.6131855156786692
MENTAL RETARDATION, X-LINKED 104; MRX104	0.016353799999999998	1.6123465015823446
PITT-HOPKINS SYNDROME	0.016353799999999998	1.6123465015823446
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.01614444	1.5917053745310616
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.01613041	1.59032213507496
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.01613041	1.59032213507496
RAYNAUD-CLAES SYNDROME; MRXSRC	0.01613041	1.59032213507496
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.01611465	1.5887683322361739
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.016106830000000003	1.5879973463098218
FRONTONASAL DYSPLASIA 2; FND2	0.016021399999999998	1.579574670134854
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.0160128	1.5787267827989688
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.0160128	1.5787267827989688
CHROMOSOME 1P36 DELETION SYNDROME	0.0160128	1.5787267827989688
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.01598853	1.5763339658638587
CHROMOSOME 16p13.2 DELETION SYNDROME	0.01576622	1.5544160782312124
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.01576622	1.5544160782312124
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.01576622	1.5544160782312124
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.01568471	1.5463798809349278
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.015640229999999998	1.5419945287604861
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.015541159999999998	1.5322270638341837
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.015393130000000001	1.517632556586374
DESANTO-SHINAWI SYNDROME	0.01539313	1.517632556586374
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.015295340000000001	1.5079912888449478
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.015295340000000001	1.5079912888449478
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.015295340000000001	1.5079912888449478
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.01520384	1.498970161957326
HAMAMY SYNDROME; HMMS	0.01520384	1.498970161957326
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.014953579999999998	1.4742966404830509
COHEN-GIBSON SYNDROME; COGIS	0.014750150000000002	1.4542401613273264
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.014750150000000002	1.4542401613273264
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.01474164	1.453401147231002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.01473387	1.4526350908821843
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.01473387	1.4526350908821843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.01473387	1.4526350908821843
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.01473387	1.4526350908821843
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.01473387	1.4526350908821843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.01473387	1.4526350908821843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.01473387	1.4526350908821843
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.01473387	1.4526350908821843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.01473387	1.4526350908821843
AICARDI-GOUTIERES SYNDROME 7	0.01473387	1.4526350908821843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.01473387	1.4526350908821843
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.014705919999999997	1.4498794570405553
NOONAN SYNDROME 7; NS7	0.01470567	1.4498548091528844
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.014698099999999999	1.4491084711142035
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.014698099999999999	1.4491084711142035
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.014698099999999999	1.4491084711142035
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.014698099999999999	1.4491084711142035
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.014698099999999999	1.4491084711142035
Aarskog-Scott syndrome	0.01450249	1.4298229778848306
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.01450249	1.4298229778848306
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.01450249	1.4298229778848306
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.01450249	1.4298229778848306
ACROCALLOSAL SYNDROME; ACLS	0.01450249	1.4298229778848306
#129490 ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT;ECTD10A;;ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL DOMINANT; HED	0.0142857	1.408449315611962
TOOTH AGENESIS, SELECTIVE, 4	0.0142857	1.408449315611962
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.0142857	1.408449315611962
TANGIER DISEASE; TGD	0.0142857	1.408449315611962
IMMUNODEFICIENCY 55; IMD55	0.0142857	1.408449315611962
AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 3; PLCA3	0.0142857	1.408449315611962
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.0142857	1.408449315611962
257960 OCULOTRICHODYSPLASIA; OTD	0.0142857	1.408449315611962
DERMOODONTODYSPLASIA	0.0142857	1.408449315611962
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.0142857	1.408449315611962
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT; ECTD11A	0.0142857	1.408449315611962
AICARDI-GOUTIERES SYNDROME 5	0.0142857	1.408449315611962
#614640 UV-SENSITIVE SYNDROME 3; UVSS3	0.0142857	1.408449315611962
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.0142857	1.408449315611962
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.0142857	1.408449315611962
MYXEDEMA	0.0142857	1.408449315611962
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.0142857	1.408449315611962
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.0142857	1.408449315611962
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.0142857	1.408449315611962
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.0142857	1.408449315611962
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0142857	1.408449315611962
ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15	0.0142857	1.408449315611962
#613216 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE	0.0142857	1.408449315611962
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.0142857	1.408449315611962
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.0142857	1.408449315611962
PEROXISOME BIOGENESIS DISORDER 14B	0.0142857	1.408449315611962
TOOTH AGENESIS, SELECTIVE, 8; STHAG8	0.0142857	1.408449315611962
#600630 UV-SENSITIVE SYNDROME 1; UVSS1	0.0142857	1.408449315611962
CRANIOECTODERMAL DYSPLASIA 3	0.0142857	1.408449315611962
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.0142857	1.408449315611962
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.0142857	1.408449315611962
COCKAYNE SYNDROME A; CSA	0.0142857	1.408449315611962
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.0142857	1.408449315611962
DERMATITIS, ATOPIC	0.0142857	1.408449315611962
HELIX SYNDROME; HELIX	0.0142857	1.408449315611962
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.0142857	1.408449315611962
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0142857	1.408449315611962
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.0142857	1.408449315611962
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.0142857	1.408449315611962
ANONYCHIA WITH FLEXURAL PIGMENTATION	0.0142857	1.408449315611962
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2	0.0142857	1.408449315611962
#300640 INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 2; IPD2	0.0142857	1.408449315611962
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.0142857	1.408449315611962
#103285 ADULT SYNDROME;;ACRO-DERMATO-UNGUAL-LACRIMAL-TOOTH SYNDROME	0.0142857	1.408449315611962
AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1; PLCA1	0.0142857	1.408449315611962
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.01425591	1.4055122733170742
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.014162659999999999	1.3963186112157548
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.01415406	1.3954707238798694
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.01415406	1.3954707238798694
LUSCAN-LUMISH SYNDROME; LLS	0.01415406	1.3954707238798694
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.014138300000000001	1.3939169210410833
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.0140247	1.3827169208833368
PALLISTER-KILLIAN SYNDROME	0.01388282	1.368728751672236
PELGER-HUET ANOMALY; PHA	0.013763539999999998	1.3569687515066018
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.013763539999999998	1.3569687515066018
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.013763539999999998	1.3569687515066018
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.013763539999999998	1.3569687515066018
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.01357508	1.3383881878646222
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.01357508	1.3383881878646222
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.01353439	1.3343764976672745
COFFIN-SIRIS SYNDROME 8; CSS8	0.01353439	1.3343764976672745
OCULOCEREBROCUTANEOUS SYNDROME	0.01332742	1.3139710044221267
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.01332742	1.3139710044221267
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.01332742	1.3139710044221267
ADAMS-OLIVER SYNDROME 1; AOS1	0.01332742	1.3139710044221267
PARC SYNDROME	0.01332742	1.3139710044221267
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.0133196	1.3132000184957746
Adrenoleukodystrophy	0.0133196	1.3132000184957746
CHROMOSOME 1p35 DELETION SYNDROME	0.01331353	1.3126015677831206
MENTAL RETARDATION, X-LINKED 102	0.01328673	1.309959314224779
MICROPHTHALMIA, SYNDROMIC 1	0.01327891	1.309188328298427
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.01309014	1.2905772012757353
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.01289141	1.270984102408227
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.01289141	1.270984102408227
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.012757520000000001	1.257783679687094
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.012757520000000001	1.257783679687094
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.012757520000000001	1.257783679687094
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.012757520000000001	1.257783679687094
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.012757520000000001	1.257783679687094
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.012757520000000001	1.257783679687094
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.012757520000000001	1.257783679687094
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.012757520000000001	1.257783679687094
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.012757520000000001	1.257783679687094
ASPARTYLGLUCOSAMINURIA; AGU	0.012757520000000001	1.257783679687094
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.01271744	1.2538321303356637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.01271744	1.2538321303356637
#614970 JOUBERT SYNDROME 20; JBTS20	0.01271744	1.2538321303356637
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.01271744	1.2538321303356637
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.01271744	1.2538321303356637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.01271744	1.2538321303356637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.01271744	1.2538321303356637
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.01271744	1.2538321303356637
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.01271744	1.2538321303356637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.01259983	1.2422367780596728
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.01259983	1.2422367780596728
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.01259983	1.2422367780596728
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.01250204	1.2325955103182467
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.01250204	1.2325955103182467
CANAVAN DISEASE	0.01250204	1.2325955103182467
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.01250204	1.2325955103182467
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.01250204	1.2325955103182467
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.01250204	1.2325955103182467
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.01250204	1.2325955103182467
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.01250204	1.2325955103182467
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.01250204	1.2325955103182467
DYSOSTEOSCLEROSIS	0.01250204	1.2325955103182467
KRABBE DISEASE	0.01250204	1.2325955103182467
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.01250204	1.2325955103182467
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.012482739999999999	1.2306926933900377
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.012482739999999999	1.2306926933900377
HYPERLYSINEMIA, TYPE I	0.012482739999999999	1.2306926933900377
DYSTONIA 16; DYT16	0.012482739999999999	1.2306926933900377
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.012482739999999999	1.2306926933900377
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.012482739999999999	1.2306926933900377
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.012482739999999999	1.2306926933900377
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.012482739999999999	1.2306926933900377
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.012482739999999999	1.2306926933900377
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.01247829	1.2302539609894922
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.012385039999999998	1.221060298888173
CYCLIC VOMITING SYNDROME	0.01222726	1.2055045240211903
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.01222726	1.2055045240211903
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.01222726	1.2055045240211903
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.01222726	1.2055045240211903
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.01222726	1.2055045240211903
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.01222726	1.2055045240211903
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.01222726	1.2055045240211903
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.01222726	1.2055045240211903
COWCHOCK SYNDROME; COWCK	0.01222726	1.2055045240211903
BARDET-BIEDL SYNDROME 16; BBS16	0.01222726	1.2055045240211903
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.011956850000000002	1.1788443828006252
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.011956850000000002	1.1788443828006252
NOONAN SYNDROME 6; NS6	0.011956850000000002	1.1788443828006252
#278250 WRINKLY SKIN SYNDROME; WSS	0.011956850000000002	1.1788443828006252
AL KAISSI SYNDROME; ALKAS	0.011956850000000002	1.1788443828006252
ECTRODACTYLY AND ECTODERMAL DYSPLASIA WITHOUT CLEFT LIP/PALATE	0.011904799999999998	1.1737126925875025
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.011904799999999998	1.1737126925875025
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.011904799999999998	1.1737126925875025
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.011904799999999998	1.1737126925875025
PARAMOLAR TUBERCLE OF BOLK	0.011904799999999998	1.1737126925875025
DENS EVAGINATUS	0.011904799999999998	1.1737126925875025
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.011904799999999998	1.1737126925875025
ERYTHEMA OF ACRAL REGIONS	0.011904799999999998	1.1737126925875025
IRIDOGONIODYSGENESIS, TYPE 2	0.011904799999999998	1.1737126925875025
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.011904799999999998	1.1737126925875025
SPLIT LOWER LIP	0.011904799999999998	1.1737126925875025
PREMATURE OVARIAN FAILURE 2B	0.011904799999999998	1.1737126925875025
OSTEOGENESIS IMPERFECTA, TYPE V	0.011904799999999998	1.1737126925875025
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.011904799999999998	1.1737126925875025
#129500 CLOUSTON SYNDROME;;ECTODERMAL DYSPLASIA 2, CLOUSTON TYPE; ECTD2;;ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT;;CLOUSTON HIDROTIC ECTODERMAL DYSPLASIA;;ECTODERMAL DYSPLASIA, HIDROTIC, 2, FORMERLY; HED2, FORMERLY	0.011904799999999998	1.1737126925875025
TOOTH SIZE	0.011904799999999998	1.1737126925875025
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.011904799999999998	1.1737126925875025
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.011904799999999998	1.1737126925875025
HYPOPHOSPHATASIA, INFANTILE	0.011904799999999998	1.1737126925875025
TEETH, ODD SHAPES OFLOBODONTIA, INCLUDED	0.011904799999999998	1.1737126925875025
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.011904799999999998	1.1737126925875025
125300 DENS IN DENTE AND PALATAL INVAGINATIONS	0.011904799999999998	1.1737126925875025
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.011904799999999998	1.1737126925875025
JABERI-ELAHI SYNDROME; JABELS	0.011904799999999998	1.1737126925875025
MICROPHTHALMIA WITH HYPEROPIA, RETINAL DEGENERATION, MACROPHAKIA,AND DENTAL ANOMALIES	0.011904799999999998	1.1737126925875025
CARABELLI ANOMALY OF MAXILLARY MOLAR TEETH	0.011904799999999998	1.1737126925875025
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.011904799999999998	1.1737126925875025
TEETH, FUSED	0.011904799999999998	1.1737126925875025
OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN BONES, BUT WITHOUT FRACTURES	0.011904799999999998	1.1737126925875025
BARDET-BIEDL SYNDROME 4; BBS4	0.011904799999999998	1.1737126925875025
CANINE TEETH, ABSENCE OF UPPER PERMANENT	0.011904799999999998	1.1737126925875025
INCISORS, FUSED MANDIBULAR	0.011904799999999998	1.1737126925875025
MOLAR I REINCLUSION	0.011904799999999998	1.1737126925875025
CORNEODERMATOOSSEOUS SYNDROME	0.011904799999999998	1.1737126925875025
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.01180069	1.1634483262457511
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.01180069	1.1634483262457511
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.01170919	1.1544271993581294
ROBERTS SYNDROME; RBS	0.01170919	1.1544271993581294
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.01170919	1.1544271993581294
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	0.01170919	1.1544271993581294
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.01170919	1.1544271993581294
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.011701370000000001	1.1536562134317776
HYPERTELORISM, TEEBI TYPE; TBHS	0.011701370000000001	1.1536562134317776
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.011701370000000001	1.1536562134317776
MENTAL RETARDATION, BUENOS AIRES TYPE	0.011701370000000001	1.1536562134317776
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.011345000000000001	1.1185211425143824
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.01133718	1.1177501565880303
#613707 LEOPARD SYNDROME 3; LPRD3	0.0112927	1.1133648044135886
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.0112314	1.1073211423566358
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.011231399999999999	1.1073211423566356
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.01112161	1.0964967760069968
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.01111379	1.0957257900806447
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.01111379	1.0957257900806447
COFFIN-SIRIS SYNDROME 7; CSS7	0.01111379	1.0957257900806447
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.01111379	1.0957257900806447
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.01111379	1.0957257900806447
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.01111379	1.0957257900806447
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.01110528	1.0948867759843206
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.01110528	1.0948867759843206
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.01108952	1.0933329731455348
SWEENEY-COX SYNDROME; SWCOS	0.01108952	1.0933329731455348
TEEBI-SHALTOUT SYNDROME; TBSH	0.01108952	1.0933329731455348
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.01108952	1.0933329731455348
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.011081700000000002	1.092561987219183
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.01086613	1.0713086066381492
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.01086613	1.0713086066381492
CHARGE SYNDROME	0.01086613	1.0713086066381492
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.01086613	1.0713086066381492
LOEYS-DIETZ SYNDROME 5	0.01086613	1.0713086066381492
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.01086613	1.0713086066381492
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.01086613	1.0713086066381492
Muenke syndrome	0.010858310000000001	1.0705376207117974
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.01074109	1.0589807191405736
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.01074109	1.0589807191405736
HYPERPROLINEMIA, TYPE I	0.01074109	1.0589807191405736
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.01074109	1.0589807191405736
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.01074109	1.0589807191405736
ADENYLOSUCCINASE DEFICIENCY	0.01074109	1.0589807191405736
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.01074109	1.0589807191405736
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.01074109	1.0589807191405736
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.01074109	1.0589807191405736
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.01074109	1.0589807191405736
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.01074109	1.0589807191405736
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.01074109	1.0589807191405736
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.01074109	1.0589807191405736
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.01074109	1.0589807191405736
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.01061955	1.0469979020703928
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.01061955	1.0469979020703928
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.010526299999999999	1.0378042399690737
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.010526299999999999	1.0378042399690737
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.010526299999999999	1.0378042399690737
#127550 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1; DKCA1;;DYSKERATOSIS CONGENITA, SCOGGINS TYPE	0.010526299999999999	1.0378042399690737
#603554 OMENN SYNDROME;;RETICULOENDOTHELIOSIS, FAMILIAL, WITH EOSINOPHILIA;;SEVERE COMBINED IMMUNODEFICIENCY WITH HYPEREOSINOPHILIA	0.010526299999999999	1.0378042399690737
#606367 IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41;;INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF;;IL2RA DEFICIENCY;;CD25 DEFICIENCY	0.010526299999999999	1.0378042399690737
Oliver-McFarlane syndrome	0.010526299999999999	1.0378042399690737
CHANARIN-DORFMAN SYNDROME	0.010526299999999999	1.0378042399690737
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.010526299999999999	1.0378042399690737
HEMOCHROMATOSIS, TYPE 1	0.010526299999999999	1.0378042399690737
HYPOTRICHOSIS 11; HYPT11	0.010526299999999999	1.0378042399690737
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.010526299999999999	1.0378042399690737
ALOPECIA, CONGENITAL	0.010526299999999999	1.0378042399690737
#602032 ECTODERMAL DYSPLASIA 4, HAIR/NAIL TYPE; ECTD4;;ECTODERMAL DYSPLASIA, 'PURE' HAIR/NAIL TYPE	0.010526299999999999	1.0378042399690737
SATOYOSHI SYNDROME	0.010526299999999999	1.0378042399690737
ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE; ECTD7	0.010526299999999999	1.0378042399690737
TRICHOTILLOMANIA; TTM	0.010526299999999999	1.0378042399690737
ECTODERMAL DYSPLASIA 6, HAIR/NAIL TYPE; ECTD6	0.010526299999999999	1.0378042399690737
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.010526299999999999	1.0378042399690737
WOODHOUSE-SAKATI SYNDROME	0.010526299999999999	1.0378042399690737
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.010526299999999999	1.0378042399690737
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.010526299999999999	1.0378042399690737
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 1; PPKCA1	0.010526299999999999	1.0378042399690737
HYPOGONADISM, PRIMARY, AND PARTIAL ALOPECIA	0.010526299999999999	1.0378042399690737
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.010526299999999999	1.0378042399690737
#262000 BJORNSTAD SYNDROME; BJS;;PILI TORTI AND NERVE DEAFNESS;;PTD	0.010526299999999999	1.0378042399690737
KNOBLOCH SYNDROME 1; KNO1	0.010526299999999999	1.0378042399690737
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.010526299999999999	1.0378042399690737
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.010526299999999999	1.0378042399690737
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.010526299999999999	1.0378042399690737
THUMB DEFORMITY AND ALOPECIA	0.010526299999999999	1.0378042399690737
ICHTHYOSIS WITH ALOPECIA, ECLABION, ECTROPION, AND MENTAL RETARDATION	0.010526299999999999	1.0378042399690737
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.010526299999999999	1.0378042399690737
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.010526299999999999	1.0378042399690737
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.010526299999999999	1.0378042399690737
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.010526299999999999	1.0378042399690737
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.010526299999999999	1.0378042399690737
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.010526299999999999	1.0378042399690737
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.010526299999999999	1.0378042399690737
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1	0.010526299999999999	1.0378042399690737
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.010526299999999999	1.0378042399690737
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.010526299999999999	1.0378042399690737
PORPHYRIA CUTANEA TARDA	0.010526299999999999	1.0378042399690737
MONILETHRIX; MNLIX	0.010526299999999999	1.0378042399690737
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.010526299999999999	1.0378042399690737
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.010526299999999999	1.0378042399690737
#203655 ALOPECIA UNIVERSALIS CONGENITA; ALUNC;;ATRICHIA, GENERALIZED	0.010526299999999999	1.0378042399690737
ALOPECIA, ANDROGENETIC, 1	0.010526299999999999	1.0378042399690737
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.010526299999999999	1.0378042399690737
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.010526299999999999	1.0378042399690737
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.010526299999999999	1.0378042399690737
T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY	0.010526299999999999	1.0378042399690737
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.010526299999999999	1.0378042399690737
CANCER, ALOPECIA, PIGMENT DYSCRASIA, ONYCHODYSTROPHY, AND KERATODERMA; CAPOK	0.010526299999999999	1.0378042399690737
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.010526299999999999	1.0378042399690737
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.010526299999999999	1.0378042399690737
#614564 CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL; FCTCS;;TELANGIECTASIA, CUTANEOUS, AND CANCER SYNDROME, FAMILIAL	0.010526299999999999	1.0378042399690737
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.010526299999999999	1.0378042399690737
VITAMIN D-DEPENDENT RICKETS, TYPE 2B, WITH NORMAL VITAMIN D RECEPTOR	0.010526299999999999	1.0378042399690737
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.010526299999999999	1.0378042399690737
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.010526299999999999	1.0378042399690737
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.010526299999999999	1.0378042399690737
#226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATAVARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED	0.010526299999999999	1.0378042399690737
#615604 L-FERRITIN DEFICIENCY; LFTD	0.010526299999999999	1.0378042399690737
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.010526299999999999	1.0378042399690737
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	0.010526299999999999	1.0378042399690737
HYPOTRICHOSIS 5; HYPT5	0.010526299999999999	1.0378042399690737
Rothmund-Thomson syndrome	0.010526299999999999	1.0378042399690737
MARIE UNNA HEREDITARY HYPOTRICHOSIS 1	0.010526299999999999	1.0378042399690737
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.01052023	1.0372057892564195
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.01052023	1.0372057892564195
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.01052023	1.0372057892564195
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.01048561	1.033792549771726
RICHARDS-RUNDLE SYNDROME; RRNS	0.01048561	1.033792549771726
JOUBERT SYNDROME 1	0.01048561	1.033792549771726
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.01048561	1.033792549771726
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.01029684	1.0151814227490341
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.01029684	1.0151814227490341
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.01029684	1.0151814227490341
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.01029684	1.0151814227490341
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.01029684	1.0151814227490341
PETERS-PLUS SYNDROME; PTRPLS	0.01024646	1.0102143804255548
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.01024646	1.0102143804255548
3MC SYNDROME 3	0.01024646	1.0102143804255548
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.01024646	1.0102143804255548
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.01024646	1.0102143804255548
LAMB-SHAFFER SYNDROME	0.01009811	0.9955883238815256
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00984263	0.9704001545126781
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00984263	0.9704001545126781
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.00984263	0.9704001545126781
GOLDBERG-SHPRINTZEN SYNDROME	0.00984263	0.9704001545126781
SCARF SYNDROME	0.00984263	0.9704001545126781
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.00984263	0.9704001545126781
Helsmoortel-van der Aa syndrome	0.00984263	0.9704001545126781
LATHOSTEROLOSIS	0.00984263	0.9704001545126781
HYPERMANGANESEMIA WITH DYSTONIA 2	0.00970874	0.9571997317915455
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00970874	0.9571997317915455
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00970874	0.9571997317915455
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.00970874	0.9571997317915455
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.00970874	0.9571997317915455
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.00970874	0.9571997317915455
SCHINDLER DISEASE, TYPE I	0.00970874	0.9571997317915455
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.00970874	0.9571997317915455
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00970874	0.9571997317915455
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.00970874	0.9571997317915455
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.00970874	0.9571997317915455
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.00970874	0.9571997317915455
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.00970874	0.9571997317915455
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.00970874	0.9571997317915455
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.00970874	0.9571997317915455
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.00970874	0.9571997317915455
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.00970874	0.9571997317915455
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.00970874	0.9571997317915455
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.00970874	0.9571997317915455
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.00970874	0.9571997317915455
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.00970874	0.9571997317915455
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.00970874	0.9571997317915455
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.00970874	0.9571997317915455
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00970874	0.9571997317915455
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00970874	0.9571997317915455
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.00970874	0.9571997317915455
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.00970874	0.9571997317915455
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.00970874	0.9571997317915455
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.00970874	0.9571997317915455
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.00970874	0.9571997317915455
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.00970874	0.9571997317915455
#271930 STRIATONIGRAL DEGENERATION, INFANTILE; SNDI;;INFANTILE BILATERAL STRIATAL NECROSIS; IBSN;;BILATERAL STRIATAL NECROSIS, INFANTILE;;STRIATAL DEGENERATION, FAMILIAL	0.00970874	0.9571997317915455
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.00970874	0.9571997317915455
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.00970874	0.9571997317915455
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.00970874	0.9571997317915455
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.00970874	0.9571997317915455
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.00970874	0.9571997317915455
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.00970874	0.9571997317915455
ALEXANDER DISEASE	0.00970874	0.9571997317915455
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.00970874	0.9571997317915455
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.00970874	0.9571997317915455
RETT SYNDROME, CONGENITAL VARIANT	0.00970874	0.9571997317915455
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.00970874	0.9571997317915455
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.00970874	0.9571997317915455
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.00970874	0.9571997317915455
AICARDI-GOUTIERES SYNDROME 6	0.00970874	0.9571997317915455
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.009684990000000001	0.9548581824627913
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00967717	0.9540871965364394
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.00967717	0.9540871965364394
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00967717	0.9540871965364394
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.00955105	0.9416528301641244
HYPERTRYPTOPHANEMIA; HYPTRP	0.00955105	0.9416528301641244
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.009478440000000001	0.9344940976689311
SPINOCEREBELLAR ATAXIA 47; SCA47	0.009478440000000001	0.9344940976689311
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.009478440000000001	0.9344940976689311
DUBOWITZ SYNDROME	0.009478440000000001	0.9344940976689311
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.009478440000000001	0.9344940976689311
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.009478440000000001	0.9344940976689311
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.00943396	0.9301087454944894
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.00943396	0.9301087454944894
SECKEL SYNDROME 4	0.00943396	0.9301087454944894
#117360 SPINOCEREBELLAR ATAXIA 29; SCA29;;CEREBELLAR ATAXIA, CONGENITAL NONPROGRESSIVE, AUTOSOMAL DOMINANT;CNPCA;;CEREBELLAR VERMIS APLASIA;;APLASIA OF CEREBELLAR VERMIS; ACV	0.00943396	0.9301087454944894
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.00943396	0.9301087454944894
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00943396	0.9301087454944894
#615418 MITOCHONDRIAL DNA DEPLETION SYNDROME 12 (CARDIOMYOPATHIC TYPE); MTDPS12	0.00943396	0.9301087454944894
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.00943396	0.9301087454944894
#300555 DENT DISEASE 2	0.00943396	0.9301087454944894
IMMUNODEFICIENCY 23; IMD23	0.00943396	0.9301087454944894
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00943396	0.9301087454944894
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.00943396	0.9301087454944894
BARDET-BIEDL SYNDROME 12; BBS12	0.00943396	0.9301087454944894
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.00943396	0.9301087454944894
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.00943396	0.9301087454944894
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.00943396	0.9301087454944894
BARDET-BIEDL SYNDROME 17; BBS17	0.00943396	0.9301087454944894
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.00943396	0.9301087454944894
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.00943396	0.9301087454944894
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00943396	0.9301087454944894
DYSTONIA 28, CHILDHOOD-ONSET	0.00943396	0.9301087454944894
SPINOCEREBELLAR ATAXIA 1	0.00943396	0.9301087454944894
#601042 DYSTONIA 9; DYT9;;CHOREOATHETOSIS/SPASTICITY, EPISODIC;;CSE CHOREOATHETOSIS, PAROXYSMAL, WITH EPISODIC ATAXIA;;CHOREOATHETOSIS, KINESIGENIC, WITH EPISODIC ATAXIA AND SPASTICITY	0.00943396	0.9301087454944894
SPINOCEREBELLAR ATAXIA 32; SCA32	0.00943396	0.9301087454944894
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.00943396	0.9301087454944894
JOUBERT SYNDROME 31; JBTS31	0.00943396	0.9301087454944894
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.00943396	0.9301087454944894
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00943396	0.9301087454944894
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00943396	0.9301087454944894
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.00943396	0.9301087454944894
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.00943396	0.9301087454944894
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00943396	0.9301087454944894
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00943396	0.9301087454944894
BARDET-BIEDL SYNDROME 18; BBS18	0.00943396	0.9301087454944894
BARDET-BIEDL SYNDROME 5; BBS5	0.00943396	0.9301087454944894
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.00943396	0.9301087454944894
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.00943396	0.9301087454944894
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00943396	0.9301087454944894
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.00943396	0.9301087454944894
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00943396	0.9301087454944894
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00943396	0.9301087454944894
SPINOCEREBELLAR ATAXIA 42	0.00943396	0.9301087454944894
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.00943396	0.9301087454944894
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.00943396	0.9301087454944894
FLOATING-HARBOR SYNDROME	0.00943396	0.9301087454944894
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.00943396	0.9301087454944894
#612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	0.00943396	0.9301087454944894
#615030 SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56	0.00943396	0.9301087454944894
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00943396	0.9301087454944894
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.00943396	0.9301087454944894
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.00943396	0.9301087454944894
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	0.00943396	0.9301087454944894
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.00943396	0.9301087454944894
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00943396	0.9301087454944894
SCHIZOPHRENIA 19; SCZD19	0.00943396	0.9301087454944894
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.00943396	0.9301087454944894
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00943396	0.9301087454944894
JOUBERT SYNDROME 4	0.00943396	0.9301087454944894
#607346 SPINOCEREBELLAR ATAXIA 19; SCA19;;SPINOCEREBELLAR ATAXIA 22; SCA22	0.00943396	0.9301087454944894
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00943396	0.9301087454944894
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.00943396	0.9301087454944894
#258501 3-@METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3;;MGA, TYPE III; MGA3;;OPTIC ATROPHY PLUS SYNDROME;;OPTIC ATROPHY, INFANTILE, WITH CHOREA AND SPASTIC PARAPLEGIA;;IRAQI-JEWISH 'OPTIC ATROPHY PLUS';;COSTEFF SYNDROME;;OPTIC ATROPHY 3, AUTOSOMAL RECESSIVE;;OPA3, AUTOSOMAL RECESSIVE	0.00943396	0.9301087454944894
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00943396	0.9301087454944894
BARDET-BIEDL SYNDROME 8; BBS8	0.00943396	0.9301087454944894
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00943396	0.9301087454944894
BARDET-BIEDL SYNDROME 10; BBS10	0.00943396	0.9301087454944894
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.00943396	0.9301087454944894
SPINOCEREBELLAR ATAXIA 5; SCA5	0.00943396	0.9301087454944894
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.00943396	0.9301087454944894
MEIER-GORLIN SYNDROME 6; MGORS6	0.00926287	0.9132407170878973
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.00926287	0.9132407170878973
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00926287	0.9132407170878973
COFFIN-SIRIS SYNDROME 6; CSS6	0.00926287	0.9132407170878973
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.00925505	0.9124697311615455
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.009230780000000001	0.9100769142264354
RENPENNING SYNDROME 1; RENS1	0.009230780000000001	0.9100769142264354
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.009230780000000001	0.9100769142264354
DEAFNESS, X-LINKED 7; DFNX7	0.00922296	0.9093059283000835
OHDO SYNDROME	0.00922296	0.9093059283000835
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00922296	0.9093059283000835
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.00922296	0.9093059283000835
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00900739	0.88805254771905
AU-KLINE SYNDROME; AUKS	0.00900739	0.88805254771905
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00900739	0.88805254771905
ACROCRANIOFACIAL DYSOSTOSIS	0.00900739	0.88805254771905
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.00900739	0.88805254771905
311450 PALLISTER W SYNDROME;;W SYNDROME	0.00890807	0.8782604349050765
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00890807	0.8782604349050765
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00890807	0.8782604349050765
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00890807	0.8782604349050765
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.00890807	0.8782604349050765
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.00890807	0.8782604349050765
ELSAHY-WATERS SYNDROME; ESWS	0.00890807	0.8782604349050765
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00890807	0.8782604349050765
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.00890807	0.8782604349050765
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.00890807	0.8782604349050765
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00890807	0.8782604349050765
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.00866149	0.8539497303373201
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.00866149	0.8539497303373201
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.00866149	0.8539497303373201
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.00866149	0.8539497303373201
CORNELIA DE LANGE SYNDROME 1	0.0086432	0.8521464908753027
EMANUEL SYNDROME	0.0086432	0.8521464908753027
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.008635380000000002	0.851375504948951
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.00854388	0.8423543780613293
CHROMOSOME 9P DELETION SYNDROME	0.00854388	0.8423543780613293
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.00854388	0.8423543780613293
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.00854388	0.8423543780613293
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.00854388	0.8423543780613293
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00854388	0.8423543780613293
#129400 RAPP-HODGKIN SYNDROME; RHS;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATEOROFACIAL CLEFT 8, INCLUDED; OFC8, INCLUDED;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 8, INCLUDED	0.008387720000000001	0.8269583215064553
SHUKLA-VERNON SYNDROME; SHUVER	0.00832049	0.8203300115539438
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.00832049	0.8203300115539438
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.00832049	0.8203300115539438
#166250 OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM	0.00832049	0.8203300115539438
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.00832049	0.8203300115539438
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.00832049	0.8203300115539438
WEAVER SYNDROME	0.00832049	0.8203300115539438
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.00832049	0.8203300115539438
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.00829622	0.8179371946188337
FRYNS SYNDROME; FRNS	0.00829622	0.8179371946188337
STROMME SYNDROME; STROMS	0.00829622	0.8179371946188337
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.00829622	0.8179371946188337
BOHRING-OPITZ SYNDROME	0.00829622	0.8179371946188337
ZUNICH NEUROECTODERMAL SYNDROME	0.00829622	0.8179371946188337
BASAL CELL NEVUS SYNDROME	0.00829622	0.8179371946188337
#613456 FRONTONASAL DYSPLASIA 3; FND3	0.00829622	0.8179371946188337
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00829622	0.8179371946188337
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.00829622	0.8179371946188337
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00829622	0.8179371946188337
TARP SYNDROME; TARPS	0.00829622	0.8179371946188337
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.00829622	0.8179371946188337
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.00829622	0.8179371946188337
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.00829622	0.8179371946188337
BARAITSER-WINTER SYNDROME 1; BRWS1	0.008288400000000001	0.8171662086924819
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.008288400000000001	0.8171662086924819
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.008288400000000001	0.8171662086924819
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.008288400000000001	0.8171662086924819
FRONTONASAL DYSPLASIA 1; FND1	0.008288400000000001	0.8171662086924819
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.008288400000000001	0.8171662086924819
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.00807391	0.7960193069861874
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.00807283	0.7959128281114481
Diamond-Blackfan anemia 1	0.00807283	0.7959128281114481
CHROMOSOME 15q25 DELETION SYNDROME	0.00807283	0.7959128281114481
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.00807283	0.7959128281114481
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.00807283	0.7959128281114481
RITSCHER-SCHINZEL SYNDROME 1	0.00807283	0.7959128281114481
#115470 CAT EYE SYNDROME; CES;;SCHMID-FRACCARO SYNDROME;;CHROMOSOME 22 PARTIAL TETRASOMY;;INV DUP(22)(q11)	0.00807283	0.7959128281114481
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00807283	0.7959128281114481
RAINE SYNDROME	0.00807283	0.7959128281114481
CHROMOSOME 18Q DELETION SYNDROME	0.00807283	0.7959128281114481
JOUBERT SYNDROME 14	0.008065010000000001	0.7951418421850964
CREE MENTAL RETARDATION SYNDROME	0.008065010000000001	0.7951418421850964
LEGIUS SYNDROME	0.008065010000000001	0.7951418421850964
NOONAN SYNDROME 4; NS4	0.008065010000000001	0.7951418421850964
POTOCKI-LUPSKI SYNDROME	0.008065010000000001	0.7951418421850964
LATERAL MENINGOCELE SYNDROME	0.008065010000000001	0.7951418421850964
NOONAN SYNDROME 8; NS8	0.008065010000000001	0.7951418421850964
COSTELLO SYNDROME; CSTLO	0.008065010000000001	0.7951418421850964
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.008065010000000001	0.7951418421850964
NOONAN SYNDROME 2; NS2	0.008065010000000001	0.7951418421850964
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.008065010000000001	0.7951418421850964
NOONAN SYNDROME 11; NS11	0.008065010000000001	0.7951418421850964
NOONAN SYNDROME 9; NS9	0.008065010000000001	0.7951418421850964
NOONAN SYNDROME 10; NS10	0.008065010000000001	0.7951418421850964
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.008065010000000001	0.7951418421850964
NOONAN SYNDROME 5; NS5	0.008065010000000001	0.7951418421850964
FRIAS SYNDROME	0.008065010000000001	0.7951418421850964
MESOMELIA-SYNOSTOSES SYNDROME	0.008065010000000001	0.7951418421850964
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.008065010000000001	0.7951418421850964
#614816 LOEYS-DIETZ SYNDROME, TYPE 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETALMANIFESTATIONS	0.008065010000000001	0.7951418421850964
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.008065010000000001	0.7951418421850964
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.00782625	0.7716021235436918
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.007818430000000001	0.77083113761734
OPTIC ATROPHY 11; OPA11	0.007818430000000001	0.77083113761734
YOU-HOOVER-FONG SYNDROME; YHFS	0.007818430000000001	0.77083113761734
Pontine tegmental cap dysplasia	0.007818430000000001	0.77083113761734
OPTICOCOCHLEODENTATE DEGENERATION	0.007818430000000001	0.77083113761734
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.007818430000000001	0.77083113761734
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.007818430000000001	0.77083113761734
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.007818430000000001	0.77083113761734
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.007818430000000001	0.77083113761734
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.007818430000000001	0.77083113761734
HADZISELIMOVIC SYNDROME	0.007818430000000001	0.77083113761734
COFFIN-SIRIS SYNDROME 5	0.007818430000000001	0.77083113761734
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.007818430000000001	0.77083113761734
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.007818430000000001	0.77083113761734
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.00770864	0.760006771267701
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00770864	0.760006771267701
DIGEORGE SYNDROME; DGS	0.00770864	0.760006771267701
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.007700820000000001	0.7592357853413491
VERVERI-BRADY SYNDROME; VERBRAS	0.007700820000000001	0.7592357853413491
SHASHI-PENA SYNDROME; SHAPNS	0.007700820000000001	0.7592357853413491
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.007700820000000001	0.7592357853413491
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.007700820000000001	0.7592357853413491
CHROMOSOME 3q13.31 DELETION SYNDROME	0.007700820000000001	0.7592357853413491
Pierpont syndrome	0.007700820000000001	0.7592357853413491
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.00769231	0.7583967712450248
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.00769231	0.7583967712450248
#614852 MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE; MCPH9	0.00769231	0.7583967712450248
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.00769231	0.7583967712450248
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.00769231	0.7583967712450248
KUFOR-RAKEB SYNDROME	0.00769231	0.7583967712450248
#137440 GERSTMANN-STRAUSSLER DISEASE; GSD;;ENCEPHALOPATHY, SUBACUTE SPONGIFORM, GERSTMANN-STRAUSSLER TYPE;;GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; GSS;;CEREBELLAR ATAXIA, PROGRESSIVE DEMENTIA, AND AMYLOID DEPOSITS IN CNS;;AMYLOIDOSIS, CEREBRAL, WITH SPONGIFORM ENCEPHALOPATHY;;PRION DEMENTIACEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED, INCLUDED	0.00769231	0.7583967712450248
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00769231	0.7583967712450248
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.00769231	0.7583967712450248
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.00769231	0.7583967712450248
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.00769231	0.7583967712450248
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.00769231	0.7583967712450248
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00769231	0.7583967712450248
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.00769231	0.7583967712450248
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.00769231	0.7583967712450248
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.00769231	0.7583967712450248
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.00769231	0.7583967712450248
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.00769231	0.7583967712450248
VELOCARDIOFACIAL SYNDROME	0.00769231	0.7583967712450248
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.00769231	0.7583967712450248
#182601 SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 2; FSP2	0.00769231	0.7583967712450248
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.00769231	0.7583967712450248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.00769231	0.7583967712450248
#276880 UROCANASE DEFICIENCY	0.00769231	0.7583967712450248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.00769231	0.7583967712450248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.00769231	0.7583967712450248
BRUNNER SYNDROME; BRNRS	0.00769231	0.7583967712450248
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.00769231	0.7583967712450248
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.00769231	0.7583967712450248
HUNTINGTON DISEASE-LIKE 1	0.00769231	0.7583967712450248
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.00769231	0.7583967712450248
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.00769231	0.7583967712450248
MENTAL RETARDATION, X-LINKED 99	0.00769231	0.7583967712450248
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00769231	0.7583967712450248
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.00769231	0.7583967712450248
CHROMOSOME 2q37 DELETION SYNDROME	0.00769231	0.7583967712450248
#137580 GILLES DE LA TOURETTE SYNDROME; GTS;;TOURETTE SYNDROME; TS;;TOURETTE DISORDERCHRONIC MOTOR TICS, INCLUDED	0.00769231	0.7583967712450248
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.00769231	0.7583967712450248
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.00769231	0.7583967712450248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.00769231	0.7583967712450248
Jawad syndrome	0.00769231	0.7583967712450248
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00769231	0.7583967712450248
LOWE OCULOCEREBRORENAL SYNDROME	0.00769231	0.7583967712450248
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00769231	0.7583967712450248
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00769231	0.7583967712450248
GLYCINE ENCEPHALOPATHY; GCE	0.00769231	0.7583967712450248
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.00769231	0.7583967712450248
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00745316	0.7348186018988535
CAMPOMELIC DYSPLASIA	0.00745316	0.7348186018988535
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00745316	0.7348186018988535
MARDEN-WALKER SYNDROME	0.00745316	0.7348186018988535
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00745316	0.7348186018988535
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.00745316	0.7348186018988535
CLEIDOCRANIAL DYSPLASIA; CCD	0.00745316	0.7348186018988535
3MC SYNDROME 1	0.00745316	0.7348186018988535
BARAITSER-WINTER SYNDROME 2; BRWS2	0.007445340000000001	0.7340476159725017
SIFRIM-HITZ-WEISS SYNDROME	0.007445340000000001	0.7340476159725017
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.0070493299999999995	0.695004375985977
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.0070493299999999995	0.695004375985977
POTOCKI-SHAFFER SYNDROME	0.0070493299999999995	0.695004375985977
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.0070493299999999995	0.695004375985977
JOUBERT SYNDROME 10	0.0070493299999999995	0.695004375985977
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.00688387	0.6786914180097383
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.00688387	0.6786914180097383
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00688387	0.6786914180097383
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.00688387	0.6786914180097383
IMMUNODEFICIENCY 49; IMD49	0.00688387	0.6786914180097383
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.00688387	0.6786914180097383
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.00688387	0.6786914180097383
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.00668514	0.6590983191422298
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.00668514	0.6590983191422298
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.00668514	0.6590983191422298
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.00668514	0.6590983191422298
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.00668514	0.6590983191422298
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.00668514	0.6590983191422298
SHORT SYNDROME	0.00668514	0.6590983191422298
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.00668514	0.6590983191422298
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.0064617500000000005	0.6370739526348445
MEIER-GORLIN SYNDROME 3; MGORS3	0.0064617500000000005	0.6370739526348445
Retinitis pigmentosa with or without skeletal anomalies	0.0064617500000000005	0.6370739526348445
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.0064617500000000005	0.6370739526348445
CHROMOSOME 19p13.13 DELETION SYNDROME	0.0064617500000000005	0.6370739526348445
SOTOS SYNDROME 2	0.0064617500000000005	0.6370739526348445
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.0064617500000000005	0.6370739526348445
CHROMOSOME 17q12 DELETION SYNDROME	0.0064617500000000005	0.6370739526348445
MAXILLOFACIAL DYSOSTOSIS	0.0064617500000000005	0.6370739526348445
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0064617500000000005	0.6370739526348445
FACIOCARDIORENAL SYNDROME	0.00643748	0.6346811356997342
ZECHI-CEIDE SYNDROME	0.00643748	0.6346811356997342
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.00643748	0.6346811356997342
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.00643748	0.6346811356997342
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00643748	0.6346811356997342
FEINGOLD SYNDROME 1; FGLDS1	0.00642966	0.6339101497733823
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.00642966	0.6339101497733823
ZIMMERMANN-LABAND SYNDROME 1	0.00642966	0.6339101497733823
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.00642966	0.6339101497733823
OCULOSKELETODENTAL SYNDROME; OCSKD	0.00642966	0.6339101497733823
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.00642966	0.6339101497733823
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00642966	0.6339101497733823
JOUBERT SYNDROME 3; JBTS3	0.00642966	0.6339101497733823
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00642966	0.6339101497733823
608028 THAI SYMPHALANGISM SYNDROME	0.00642966	0.6339101497733823
%300712 CRANIOFACIOSKELETAL SYNDROME	0.00621409	0.6126567691923488
TREACHER COLLINS SYNDROME 3; TCS3	0.00621409	0.6126567691923488
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00621409	0.6126567691923488
SECKEL SYNDROME 1; SCKL1	0.00621409	0.6126567691923488
#263750 POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS;;MILLER SYNDROME;;GENEE-WIEDEMANN SYNDROME	0.00621409	0.6126567691923488
TREACHER COLLINS SYNDROME 2; TCS2	0.00621409	0.6126567691923488
#602398 DESMOSTEROLOSIS	0.00621409	0.6126567691923488
AGNATHIA-OTOCEPHALY COMPLEX	0.00621409	0.6126567691923488
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00621409	0.6126567691923488
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.00621409	0.6126567691923488
GENITOPATELLAR SYNDROME; GTPTS	0.00620627	0.6118857832659969
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.00620627	0.6118857832659969
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00620627	0.6118857832659969
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00620627	0.6118857832659969
PROTEUS SYNDROME	0.00620627	0.6118857832659969
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.00620627	0.6118857832659969
2p15-16.1 microdeletion syndrome	0.00620627	0.6118857832659969
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00620627	0.6118857832659969
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.00620627	0.6118857832659969
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.00620627	0.6118857832659969
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00620627	0.6118857832659969
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00620627	0.6118857832659969
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00620627	0.6118857832659969
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0058499	0.5767507123486015
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.0058499	0.5767507123486015
TEMPLE SYNDROME	0.0058499	0.5767507123486015
BARATELA-SCOTT SYNDROME	0.0058499	0.5767507123486015
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00584208	0.5759797264222497
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00584208	0.5759797264222497
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00584208	0.5759797264222497
Orofaciodigital syndrome XVII	0.00584208	0.5759797264222497
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00584208	0.5759797264222497
#605407 SEGAWA SYNDROME, AUTOSOMAL RECESSIVE;;PARKINSONISM, INFANTILE, AUTOSOMAL RECESSIVE;;DYSTONIA, DOPA-RESPONSIVE, AUTOSOMAL RECESSIVE;;DOPA-RESPONSIVE DYSTONIA, AUTOSOMAL RECESSIVE;;TYROSINE HYDROXYLASE DEFICIENCY	0.00584208	0.5759797264222497
#300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA;;BRUTON-TYPE AGAMMAGLOBULINEMIA;;AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1; AGMX1;;IMMUNODEFICIENCY 1; IMD1HYPOGAMMAGLOBULINEMIA, X-LINKED, INCLUDED	0.00584208	0.5759797264222497
WIEACKER-WOLFF SYNDROME	0.00584208	0.5759797264222497
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00584208	0.5759797264222497
CHROMOSOME 5Q12 DELETION SYNDROME	0.00584208	0.5759797264222497
PELIZAEUS-MERZBACHER DISEASE	0.00584208	0.5759797264222497
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.00584208	0.5759797264222497
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.00584208	0.5759797264222497
JOUBERT SYNDROME 30; JBTS30	0.00584208	0.5759797264222497
MECKEL SYNDROME, TYPE 10; MKS10	0.00559442	0.5515625429797542
#222600 DIASTROPHIC DYSPLASIA;;DTD;;DDDIASTROPHIC DYSPLASIA, BROAD BONE-PLATYSPONDYLIC VARIANT, INCLUDED	0.00559442	0.5515625429797542
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.00559442	0.5515625429797542
#300867 KABUKI SYNDROME 2; KABUK2	0.00559442	0.5515625429797542
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00559442	0.5515625429797542
CHARGE-LIKE SYNDROME, X-LINKED	0.00559442	0.5515625429797542
TYSHCHENKO SYNDROME	0.00559442	0.5515625429797542
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00559442	0.5515625429797542
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.00559442	0.5515625429797542
NAIL-PATELLA SYNDROME	0.00559442	0.5515625429797542
MEIER-GORLIN SYNDROME 7	0.00559442	0.5515625429797542
CDAGS SYNDROME	0.00559442	0.5515625429797542
MEIER-GORLIN SYNDROME 1; MGORS1	0.00559442	0.5515625429797542
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00559442	0.5515625429797542
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.00559442	0.5515625429797542
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.00559442	0.5515625429797542
AASE-SMITH SYNDROME I	0.00559442	0.5515625429797542
HARDIKAR SYNDROME	0.00559442	0.5515625429797542
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00559442	0.5515625429797542
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.00559442	0.5515625429797542
RAPADILINO SYNDROME	0.00559442	0.5515625429797542
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00559442	0.5515625429797542
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.00559442	0.5515625429797542
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.005586600000000001	0.5507915570534022
#614153 SPINOCEREBELLAR ATAXIA 36; SCA36	0.005586600000000001	0.5507915570534022
MUCOPOLYSACCHARIDOSIS, TYPE II	0.005586600000000001	0.5507915570534022
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.005586600000000001	0.5507915570534022
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0054951	0.5417704301657807
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0054951	0.5417704301657807
#614976 CARPENTER SYNDROME 2; CRPT2	0.0054951	0.5417704301657807
#218400 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	0.0054951	0.5417704301657807
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.0054951	0.5417704301657807
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.0054951	0.5417704301657807
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.0054951	0.5417704301657807
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0054951	0.5417704301657807
DIAMOND-BLACKFAN ANEMIA 8	0.0054951	0.5417704301657807
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.0054951	0.5417704301657807
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.0054951	0.5417704301657807
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.0054951	0.5417704301657807
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.0054951	0.5417704301657807
STEEL SYNDROME; STLS	0.0054951	0.5417704301657807
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.0054951	0.5417704301657807
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.0054951	0.5417704301657807
OROFACIODIGITAL SYNDROME XV; OFD15	0.0054951	0.5417704301657807
ROIFMAN-CHITAYAT SYNDROME	0.0054951	0.5417704301657807
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.0054951	0.5417704301657807
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.0054951	0.5417704301657807
CHROMOSOME 18P DELETION SYNDROME	0.0054951	0.5417704301657807
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.0054951	0.5417704301657807
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.0054951	0.5417704301657807
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0054951	0.5417704301657807
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.0054951	0.5417704301657807
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.0054951	0.5417704301657807
CHROMOSOME 16Q22 DELETION SYNDROME	0.0054951	0.5417704301657807
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.0054951	0.5417704301657807
600736 VELOFACIOSKELETAL SYNDROME	0.0054951	0.5417704301657807
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.0054951	0.5417704301657807
WAARDENBURG SYNDROME, TYPE 1; WS1	0.0054951	0.5417704301657807
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.00527171	0.5197460636583953
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00527171	0.5197460636583953
#101600 PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROMECRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	0.00527171	0.5197460636583953
TEMTAMY SYNDROME; TEMTYS	0.00527171	0.5197460636583953
NOONAN SYNDROME 3; NS3	0.00527171	0.5197460636583953
MEESTER-LOEYS SYNDROME; MRLS	0.00527171	0.5197460636583953
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.00527171	0.5197460636583953
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00527171	0.5197460636583953
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00527171	0.5197460636583953
XIA-GIBBS SYNDROME	0.00527171	0.5197460636583953
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.00527171	0.5197460636583953
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00527171	0.5197460636583953
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00527171	0.5197460636583953
#212780 CENANI-LENZ SYNDACTYLY SYNDROME; CLSS;;CENANI SYNDACTYLISM;;CENANI-LENZ SYNDACTYLY;;SYNDACTYLY, TYPE VII	0.00527171	0.5197460636583953
SMITH-KINGSMORE SYNDROME; SKS	0.00527171	0.5197460636583953
AUTISM, SUSCEPTIBILITY TO, 18	0.00527171	0.5197460636583953
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.00527171	0.5197460636583953
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.00527171	0.5197460636583953
FONTAINE PROGEROID SYNDROME; FPS	0.00527171	0.5197460636583953
ARTERIAL TORTUOSITY SYNDROME	0.00527171	0.5197460636583953
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00527171	0.5197460636583953
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.00527171	0.5197460636583953
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.00527171	0.5197460636583953
THAUVIN-ROBINET-FAIVRE SYNDROME	0.00527171	0.5197460636583953
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00527171	0.5197460636583953
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00527171	0.5197460636583953
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.00527171	0.5197460636583953
ATKIN-FLAITZ SYNDROME	0.00527171	0.5197460636583953
COFFIN-LOWRY SYNDROME; CLS	0.00527171	0.5197460636583953
RING CHROMOSOME 14 SYNDROME	0.00527171	0.5197460636583953
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.00527171	0.5197460636583953
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00527171	0.5197460636583953
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.00527171	0.5197460636583953
FRANK-TER HAAR SYNDROME; FTHS	0.00527171	0.5197460636583953
MENTAL RETARDATION, X-LINKED 91; MRX91	0.00502513	0.4954353590906388
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00502513	0.4954353590906388
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.00502513	0.4954353590906388
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.00502513	0.4954353590906388
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00502513	0.4954353590906388
Xq28 (MECP2) duplication	0.00502513	0.4954353590906388
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.00502513	0.4954353590906388
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.00502513	0.4954353590906388
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.00502513	0.4954353590906388
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.00502513	0.4954353590906388
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.00502513	0.4954353590906388
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00502513	0.4954353590906388
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.00502513	0.4954353590906388
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.00502513	0.4954353590906388
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.00502513	0.4954353590906388
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.00502513	0.4954353590906388
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.00502513	0.4954353590906388
PEHO-LIKE SYNDROME; PEHOL	0.00502513	0.4954353590906388
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.00502513	0.4954353590906388
LISSENCEPHALY 8; LIS8	0.00502513	0.4954353590906388
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00502513	0.4954353590906388
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.00502513	0.4954353590906388
SCHAAF-YANG SYNDROME; SHFYNG	0.00502513	0.4954353590906388
MENTAL RETARDATION, X-LINKED 101; MRX101	0.00502513	0.4954353590906388
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.00502513	0.4954353590906388
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.00502513	0.4954353590906388
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.00502513	0.4954353590906388
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.00502513	0.4954353590906388
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.00502513	0.4954353590906388
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.00502513	0.4954353590906388
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.00502513	0.4954353590906388
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.00502513	0.4954353590906388
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.00502513	0.4954353590906388
JOUBERT SYNDROME 24	0.00502513	0.4954353590906388
WARBURG MICRO SYNDROME 2; WARBM2	0.00502513	0.4954353590906388
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.00502513	0.4954353590906388
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.00502513	0.4954353590906388
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.00502513	0.4954353590906388
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.00502513	0.4954353590906388
MUCOLIPIDOSIS IV; ML4	0.00502513	0.4954353590906388
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.00502513	0.4954353590906388
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.00502513	0.4954353590906388
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.00502513	0.4954353590906388
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.00502513	0.4954353590906388
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.00502513	0.4954353590906388
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.00502513	0.4954353590906388
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00502513	0.4954353590906388
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.00502513	0.4954353590906388
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.00502513	0.4954353590906388
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.00502513	0.4954353590906388
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.00502513	0.4954353590906388
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00502513	0.4954353590906388
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.00502513	0.4954353590906388
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.00502513	0.4954353590906388
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.00502513	0.4954353590906388
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.00502513	0.4954353590906388
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.00502513	0.4954353590906388
AL-RAQAD SYNDROME; ARS	0.00502513	0.4954353590906388
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.00502513	0.4954353590906388
MENTAL RETARDATION, X-LINKED 103	0.00502513	0.4954353590906388
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00502513	0.4954353590906388
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.00502513	0.4954353590906388
MENTAL RETARDATION, X-LINKED 98; MRX98	0.00502513	0.4954353590906388
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.00502513	0.4954353590906388
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00502513	0.4954353590906388
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.00502513	0.4954353590906388
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.00502513	0.4954353590906388
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.00502513	0.4954353590906388
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.00502513	0.4954353590906388
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.00502513	0.4954353590906388
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00502513	0.4954353590906388
ANGELMAN SYNDROME	0.00502513	0.4954353590906388
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.00502513	0.4954353590906388
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.00502513	0.4954353590906388
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.00502513	0.4954353590906388
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.00502513	0.4954353590906388
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.00502513	0.4954353590906388
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.00502513	0.4954353590906388
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.00502513	0.4954353590906388
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.00502513	0.4954353590906388
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.00502513	0.4954353590906388
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.00502513	0.4954353590906388
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.00502513	0.4954353590906388
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.00502513	0.4954353590906388
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.00502513	0.4954353590906388
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00502513	0.4954353590906388
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.00502513	0.4954353590906388
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.00502513	0.4954353590906388
Congenital disorder of glycosylation, type IIh	0.00502513	0.4954353590906388
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.00502513	0.4954353590906388
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.00502513	0.4954353590906388
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00502513	0.4954353590906388
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.00502513	0.4954353590906388
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.00502513	0.4954353590906388
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.00502513	0.4954353590906388
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00502513	0.4954353590906388
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.00502513	0.4954353590906388
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.00502513	0.4954353590906388
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.00502513	0.4954353590906388
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00502513	0.4954353590906388
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.00502513	0.4954353590906388
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.00502513	0.4954353590906388
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.00490752	0.48384000681464795
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.00490752	0.48384000681464795
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.00490752	0.48384000681464795
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.00490752	0.48384000681464795
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.00490752	0.48384000681464795
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.00490752	0.48384000681464795
CHITAYAT SYNDROME	0.00490752	0.48384000681464795
#614438 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B;;DE BARSY SYNDROME B	0.00490752	0.48384000681464795
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.00490752	0.48384000681464795
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.00490752	0.48384000681464795
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.00490752	0.48384000681464795
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00465986	0.45942282337215246
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.00465986	0.45942282337215246
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00465986	0.45942282337215246
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00465986	0.45942282337215246
VICI SYNDROME; VICIS	0.00465986	0.45942282337215246
NEU-LAXOVA SYNDROME 2; NLS2	0.00465986	0.45942282337215246
KNIEST-LIKE DYSPLASIA, LETHAL	0.00465986	0.45942282337215246
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.00465986	0.45942282337215246
MELNICK-NEEDLES SYNDROME	0.00465986	0.45942282337215246
%608572 BURN-MCKEOWN SYNDROME	0.00465986	0.45942282337215246
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.00465986	0.45942282337215246
#154780 MARSHALL SYNDROME; MRSHS	0.00465986	0.45942282337215246
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.00465986	0.45942282337215246
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.00465986	0.45942282337215246
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00465986	0.45942282337215246
OROFACIODIGITAL SYNDROME V; OFD5	0.00465986	0.45942282337215246
NEMALINE MYOPATHY 2; NEM2	0.00465986	0.45942282337215246
DIAPHANOSPONDYLODYSOSTOSIS	0.00465986	0.45942282337215246
HARTSFIELD SYNDROME; HRTFDS	0.00465986	0.45942282337215246
#150250 LARSEN SYNDROME; LRS	0.00465986	0.45942282337215246
BARTSOCAS-PAPAS SYNDROME; BPS	0.00465986	0.45942282337215246
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.00465986	0.45942282337215246
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00465986	0.45942282337215246
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00465986	0.45942282337215246
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.00465986	0.45942282337215246
Temtamy preaxial brachydactyly syndrome	0.00465986	0.45942282337215246
Mental retardation, autosomal dominant 21	0.00465986	0.45942282337215246
OROFACIODIGITAL SYNDROME VIII; OFD8	0.00465986	0.45942282337215246
OROFACIODIGITAL SYNDROME VI	0.00465986	0.45942282337215246
CEREBROOCULONASAL SYNDROME	0.00465986	0.45942282337215246
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.00465986	0.45942282337215246
MECKEL SYNDROME, TYPE 1; MKS1	0.00465986	0.45942282337215246
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.00465986	0.45942282337215246
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00465986	0.45942282337215246
#256520 NEU-LAXOVA SYNDROME; NLS	0.00465986	0.45942282337215246
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.00465986	0.45942282337215246
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.00465986	0.45942282337215246
LARSEN-LIKE SYNDROME	0.00465986	0.45942282337215246
LOEYS-DIETZ SYNDROME 3; LDS3	0.00465986	0.45942282337215246
OROFACIODIGITAL SYNDROME IV; OFD4	0.00465986	0.45942282337215246
CHAR SYNDROME	0.0046520400000000005	0.45865183744580057
COACH SYNDROME	0.0046520400000000005	0.45865183744580057
#170100 PROLIDASE DEFICIENCY	0.0046520400000000005	0.45865183744580057
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0046520400000000005	0.45865183744580057
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.0046520400000000005	0.45865183744580057
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.0046520400000000005	0.45865183744580057
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.0046520400000000005	0.45865183744580057
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.0046520400000000005	0.45865183744580057
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.0046520400000000005	0.45865183744580057
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.0046520400000000005	0.45865183744580057
MCDONOUGH SYNDROME	0.0046520400000000005	0.45865183744580057
CRANIOSYNOSTOSIS 6; CRS6	0.0046520400000000005	0.45865183744580057
CHOPS SYNDROME; CHOPS	0.0046520400000000005	0.45865183744580057
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.0046520400000000005	0.45865183744580057
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.0046520400000000005	0.45865183744580057
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.0046520400000000005	0.45865183744580057
JACOBSEN SYNDROME	0.0046520400000000005	0.45865183744580057
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.0046520400000000005	0.45865183744580057
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.0046520400000000005	0.45865183744580057
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.0046520400000000005	0.45865183744580057
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.0046520400000000005	0.45865183744580057
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.0046520400000000005	0.45865183744580057
YUNIS-VARON SYNDROME	0.0046520400000000005	0.45865183744580057
SCLEROSTEOSIS 2; SOST2	0.0046520400000000005	0.45865183744580057
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00363636	0.35851437124668123
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00363636	0.35851437124668123
C SYNDROME	0.00363636	0.35851437124668123
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00363636	0.35851437124668123
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.00363636	0.35851437124668123
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00363636	0.35851437124668123
OCULOECTODERMAL SYNDROME; OES	0.00363636	0.35851437124668123
BOOMERANG DYSPLASIA	0.00363636	0.35851437124668123
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.00363636	0.35851437124668123
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00363636	0.35851437124668123
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00363636	0.35851437124668123
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00363636	0.35851437124668123
CRANIOECTODERMAL DYSPLASIA 1	0.00363636	0.35851437124668123
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00363636	0.35851437124668123
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00363636	0.35851437124668123
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00363636	0.35851437124668123
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00363636	0.35851437124668123
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00363636	0.35851437124668123
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.00363636	0.35851437124668123
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00363636	0.35851437124668123
#612713 KAHRIZI SYNDROME; KHRZ;;MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE	0.00363636	0.35851437124668123
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.00363636	0.35851437124668123
FILIPPI SYNDROME; FLPIS	0.00363636	0.35851437124668123
#193510 WAARDENBURG SYNDROME, TYPE 2A; WS2A;;WAARDENBURG SYNDROME, TYPE IIA;;WAARDENBURG SYNDROME WITHOUT DYSTOPIA CANTHORUM;;WS2	0.00363636	0.35851437124668123
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.00363636	0.35851437124668123
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.00363636	0.35851437124668123
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.00363636	0.35851437124668123
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.00363636	0.35851437124668123
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.00363636	0.35851437124668123
ALAZAMI SYNDROME; ALAZS	0.00363636	0.35851437124668123
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.00363636	0.35851437124668123
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00363636	0.35851437124668123
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00363636	0.35851437124668123
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.00363636	0.35851437124668123
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.00363636	0.35851437124668123
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.00363636	0.35851437124668123
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00363636	0.35851437124668123
MICROPHTHALMIA, SYNDROMIC 12	0.00363636	0.35851437124668123
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.00363636	0.35851437124668123
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.00363636	0.35851437124668123
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.00363636	0.35851437124668123
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00363636	0.35851437124668123
MECKEL SYNDROME 12; MKS12	0.00363636	0.35851437124668123
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00363636	0.35851437124668123
OMODYSPLASIA 1; OMOD1	0.00363636	0.35851437124668123
GLUTAMINE DEFICIENCY, CONGENITAL	0.00363636	0.35851437124668123
TRISOMY 18-LIKE SYNDROME	0.00363636	0.35851437124668123
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00363636	0.35851437124668123
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.00363636	0.35851437124668123
SIMOSA CRANIOFACIAL SYNDROME	0.00363636	0.35851437124668123
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00363636	0.35851437124668123
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.00363636	0.35851437124668123
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00363636	0.35851437124668123
BEEMER LETHAL MALFORMATION SYNDROME	0.00363636	0.35851437124668123
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.00363636	0.35851437124668123
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00363636	0.35851437124668123
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	0.00363636	0.35851437124668123
LISSENCEPHALY, X-LINKED, 2	0.00363636	0.35851437124668123
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.00363636	0.35851437124668123
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.00341297	0.3364900047392958
CHROMOSOME 16p13.3 DELETION SYNDROME	0.00341297	0.3364900047392958
Cat-Eye Syndrome (Type I)	0.00341297	0.3364900047392958
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.00341297	0.3364900047392958
RUVALCABA SYNDROME	0.00341297	0.3364900047392958
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00341297	0.3364900047392958
COHEN SYNDROME	0.00341297	0.3364900047392958
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.00341297	0.3364900047392958
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.00341297	0.3364900047392958
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.00341297	0.3364900047392958
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00341297	0.3364900047392958
171480 PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA;;FACIOAURICULORADIAL DYSPLASIA	0.00341297	0.3364900047392958
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.00341297	0.3364900047392958
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00341297	0.3364900047392958
VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE	0.00341297	0.3364900047392958
ACRORENAL-MANDIBULAR SYNDROME	0.00341297	0.3364900047392958
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00341297	0.3364900047392958
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00341297	0.3364900047392958
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00341297	0.3364900047392958
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.00341297	0.3364900047392958
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.00341297	0.3364900047392958
ROIFMAN SYNDROME; RFMN	0.00341297	0.3364900047392958
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.00341297	0.3364900047392958
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00341297	0.3364900047392958
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00341297	0.3364900047392958
MEVALONIC ACIDURIA; MEVA	0.00341297	0.3364900047392958
CHROMOSOME 17P13.1 DELETION SYNDROME	0.00341297	0.3364900047392958
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00341297	0.3364900047392958
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.00341297	0.3364900047392958
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.00341297	0.3364900047392958
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00341297	0.3364900047392958
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00341297	0.3364900047392958
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.00341297	0.3364900047392958
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00341297	0.3364900047392958
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00341297	0.3364900047392958
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.00341297	0.3364900047392958
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00341297	0.3364900047392958
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00341297	0.3364900047392958
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00341297	0.3364900047392958
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00341297	0.3364900047392958
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00341297	0.3364900047392958
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00341297	0.3364900047392958
611961 STEVENSON-CAREY SYNDROME	0.00341297	0.3364900047392958
GABA-TRANSAMINASE DEFICIENCY	0.00341297	0.3364900047392958
MARTSOLF SYNDROME	0.00341297	0.3364900047392958
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.00341297	0.3364900047392958
MARFAN SYNDROME; MFS	0.00341297	0.3364900047392958
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00341297	0.3364900047392958
SECKEL SYNDROME 5; SCKL5	0.00341297	0.3364900047392958
CLARK-BARAITSER SYNDROME	0.00341297	0.3364900047392958
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	0.00341297	0.3364900047392958
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.00341297	0.3364900047392958
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.00304878	0.30058394789554854
MENTAL RETARDATION, X-LINKED 95	0.00304878	0.30058394789554854
#614728 SECKEL SYNDROME 6; SCKL6	0.00304878	0.30058394789554854
#300705 MENTAL RETARDATION, X-LINKED 17; MRX17;;MENTAL RETARDATION, X-LINKED 31; MRX31	0.00304878	0.30058394789554854
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.00304878	0.30058394789554854
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.00304878	0.30058394789554854
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00304878	0.30058394789554854
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.00304878	0.30058394789554854
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.00304878	0.30058394789554854
FG SYNDROME 2; FGS2	0.00304878	0.30058394789554854
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00304878	0.30058394789554854
HAREL-YOON SYNDROME; HAYOS	0.00304878	0.30058394789554854
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00304878	0.30058394789554854
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.00304878	0.30058394789554854
PRADER-WILLI SYNDROME; PWS	0.00304878	0.30058394789554854
KLEEFSTRA SYNDROME 2; KLEFS2	0.00304878	0.30058394789554854
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.00304878	0.30058394789554854
CHROMOSOME 13q14 DELETION SYNDROME	0.00304878	0.30058394789554854
MENTAL RETARDATION, X-LINKED 90	0.00304878	0.30058394789554854
MENTAL RETARDATION, X-LINKED 9	0.00304878	0.30058394789554854
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.00304878	0.30058394789554854
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.00304878	0.30058394789554854
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.00304878	0.30058394789554854
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.00304878	0.30058394789554854
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.00304878	0.30058394789554854
BRACHYDACTYLY, TYPE A1, D	0.00304878	0.30058394789554854
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.00304878	0.30058394789554854
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.00304878	0.30058394789554854
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.00304878	0.30058394789554854
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.00304878	0.30058394789554854
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00304878	0.30058394789554854
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.00304878	0.30058394789554854
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.00304878	0.30058394789554854
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.00304878	0.30058394789554854
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.00304878	0.30058394789554854
COFFIN-SIRIS SYNDROME 2; CSS2	0.00304878	0.30058394789554854
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00304878	0.30058394789554854
TENORIO SYNDROME; TNORS	0.00304878	0.30058394789554854
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.00304878	0.30058394789554854
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.00304878	0.30058394789554854
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.00304878	0.30058394789554854
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.00304878	0.30058394789554854
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.00304878	0.30058394789554854
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.00304878	0.30058394789554854
Recurrent 16p12.1 microdeletion (neurodevelopmental susceptibility locus)	0.00304878	0.30058394789554854
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.00304878	0.30058394789554854
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.00304878	0.30058394789554854
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.00304878	0.30058394789554854
Cerebral creatine deficiency syndrome 2	0.00304878	0.30058394789554854
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00304878	0.30058394789554854
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.00304878	0.30058394789554854
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.00304878	0.30058394789554854
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.00304878	0.30058394789554854
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.00304878	0.30058394789554854
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.00304878	0.30058394789554854
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00304878	0.30058394789554854
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.00304878	0.30058394789554854
8p23.1 duplication syndrome	0.00304878	0.30058394789554854
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.00304878	0.30058394789554854
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.00304878	0.30058394789554854
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.00304878	0.30058394789554854
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00304878	0.30058394789554854
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00304878	0.30058394789554854
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.00304878	0.30058394789554854
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00304878	0.30058394789554854
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00304878	0.30058394789554854
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00304878	0.30058394789554854
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.00304878	0.30058394789554854
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.00304878	0.30058394789554854
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.00304878	0.30058394789554854
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.00304878	0.30058394789554854
RETINITIS PIGMENTOSA 71; RP71	0.00304878	0.30058394789554854
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00304878	0.30058394789554854
22q11 deletion syndrome (Velocardiofacial / DiGeorge syndrome)	0.00304878	0.30058394789554854
HYPOGLOSSIA WITH SITUS INVERSUS	0.00304878	0.30058394789554854
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00304878	0.30058394789554854
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.00304878	0.30058394789554854
#615328 SHAHEEN SYNDROME; SHNS	0.00304878	0.30058394789554854
AUTISM	0.00304878	0.30058394789554854
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.00304878	0.30058394789554854
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.00304878	0.30058394789554854
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00304878	0.30058394789554854
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00304878	0.30058394789554854
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00304878	0.30058394789554854
LANDAU-KLEFFNER SYNDROME	0.00304878	0.30058394789554854
EPILEPSY, PYRIDOXINE-DEPENDENT	0.00304878	0.30058394789554854
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.00304878	0.30058394789554854
BARDET-BIEDL SYNDROME 21; BBS21	0.00304878	0.30058394789554854
#615633 SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11	0.00304878	0.30058394789554854
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.00304878	0.30058394789554854
LIG4 SYNDROME	0.00304878	0.30058394789554854
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.00304878	0.30058394789554854
MENTAL RETARDATION, X-LINKED 93	0.00304878	0.30058394789554854
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.00304878	0.30058394789554854
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00304878	0.30058394789554854
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.00304878	0.30058394789554854
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.00304878	0.30058394789554854
GALACTOSE EPIMERASE DEFICIENCY	0.00304878	0.30058394789554854
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.00304878	0.30058394789554854
FORSYTHE-WAKELING SYNDROME; FWS	0.00304878	0.30058394789554854
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00304878	0.30058394789554854
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00304878	0.30058394789554854
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.00304878	0.30058394789554854
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.00304878	0.30058394789554854
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00304878	0.30058394789554854
SAUL-WILSON SYNDROME; SWILS	0.00304878	0.30058394789554854
XQ25 DUPLICATION SYNDROME	0.00304878	0.30058394789554854
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00304878	0.30058394789554854
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00304878	0.30058394789554854
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00304878	0.30058394789554854
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.00304878	0.30058394789554854
GERODERMA OSTEODYSPLASTICUM; GO	0.00304878	0.30058394789554854
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.00304878	0.30058394789554854
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00304878	0.30058394789554854
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.00304878	0.30058394789554854
MENTAL RETARDATION, X-LINKED 19	0.00304878	0.30058394789554854
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.00304878	0.30058394789554854
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.00304878	0.30058394789554854
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00304878	0.30058394789554854
CRANIOSYNOSTOSIS 7	0.00304878	0.30058394789554854
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.00304878	0.30058394789554854
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.00304878	0.30058394789554854
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00304878	0.30058394789554854
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00304878	0.30058394789554854
7q11.23 duplication syndrome	0.00304878	0.30058394789554854
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00304878	0.30058394789554854
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.00304878	0.30058394789554854
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.00304878	0.30058394789554854
SALLA DISEASE	0.00304878	0.30058394789554854
22q13 deletion syndrome (Phelan-Mcdermid syndrome)	0.00304878	0.30058394789554854
224550 DYSTONIA WITH RINGBINDEN	0.00304878	0.30058394789554854
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00304878	0.30058394789554854
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.00304878	0.30058394789554854
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.00304878	0.30058394789554854
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.00304878	0.30058394789554854
Cerebral creatine deficiency syndrome 3	0.00304878	0.30058394789554854
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00280112	0.276166764453053
Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	0.00280112	0.276166764453053
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.00280112	0.276166764453053
MICROPHTHALMIA, SYNDROMIC 4	0.00280112	0.276166764453053
DYSTONIA, JUVENILE-ONSET	0.00280112	0.276166764453053
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.00280112	0.276166764453053
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00280112	0.276166764453053
#607361 MECKEL SYNDROME, TYPE 3; MKS3;;MECKEL-GRUBER SYNDROME, TYPE 3	0.00280112	0.276166764453053
#606713 VAN DER WOUDE SYNDROME 2; VWS2	0.00280112	0.276166764453053
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.00280112	0.276166764453053
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00280112	0.276166764453053
HYDROLETHALUS SYNDROME 1	0.00280112	0.276166764453053
POPLITEAL PTERYGIUM SYNDROME	0.00280112	0.276166764453053
#137215 GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC;;GASTRIC CANCER, FAMILIAL DIFFUSEGASTRIC CANCER, FAMILIAL DIFFUSE, AND CLEFT LIP WITH OR WITHOUT CLEFTPALATE, INCLUDED	0.00280112	0.276166764453053
#215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA	0.00280112	0.276166764453053
STICKLER SYNDROME, TYPE II	0.00280112	0.276166764453053
OROFACIAL CLEFT 6, SUSCEPTIBILITY TO; OFC6	0.00280112	0.276166764453053
MECKEL SYNDROME, TYPE 6; MKS6	0.00280112	0.276166764453053
LYMPHEDEMA, HEREDITARY, II	0.00280112	0.276166764453053
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.00280112	0.276166764453053
260150 PALANT CLEFT PALATE SYNDROME	0.00280112	0.276166764453053
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.00280112	0.276166764453053
RADIUS, APLASIA OF, WITH CLEFT LIP/PALATE	0.00280112	0.276166764453053
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.00280112	0.276166764453053
Split hand/foot malformation 1 (SHFM1)	0.00280112	0.276166764453053
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.00280112	0.276166764453053
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	0.00280112	0.276166764453053
#615731 NEMALINE MYOPATHY 9; NEM9	0.00280112	0.276166764453053
#608874 OROFACIAL CLEFT 5; OFC5;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 5	0.00280112	0.276166764453053
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00280112	0.276166764453053
#614120 HYDROLETHALUS SYNDROME 2; HLS2	0.00280112	0.276166764453053
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00280112	0.276166764453053
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00280112	0.276166764453053
CLEFT PALATE, X-LINKED	0.00280112	0.276166764453053
BRANCHIOOTORENAL SYNDROME 1	0.00280112	0.276166764453053
#612290 MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATEMICROTIA WITH OR WITHOUT HEARING IMPAIRMENT, INCLUDED	0.00280112	0.276166764453053
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.00280112	0.276166764453053
SAY SYNDROME	0.00280112	0.276166764453053
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.00280112	0.276166764453053
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.00280112	0.276166764453053
THORACOABDOMINAL SYNDROME	0.00280112	0.276166764453053
NIJMEGEN BREAKAGE SYNDROME	0.00280112	0.276166764453053
HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA	0.00280112	0.276166764453053
MESOMELIC LIMB SHORTENING AND BOWING	0.00280112	0.276166764453053
PALATOPHARYNGEAL INCOMPETENCE	0.00280112	0.276166764453053
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.00280112	0.276166764453053
#184250 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK;;SEMD, STRUDWICK TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE;;SMED, STRUDWICK TYPE;;SMED, TYPE I;;STRUDWICK SYNDROME;;DAPPLED METAPHYSIS SYNDROME;;SPONDYLOMETAPHYSEAL DYSPLASIA; SMD;;SEMDC	0.00280112	0.276166764453053
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00280112	0.276166764453053
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.00280112	0.276166764453053
SCHNECKENBECKEN DYSPLASIA	0.00280112	0.276166764453053
MECKEL SYNDROME, TYPE 5	0.00280112	0.276166764453053
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.00280112	0.276166764453053
#273395 TETRAAMELIA, AUTOSOMAL RECESSIVE	0.00280112	0.276166764453053
MECKEL SYNDROME, TYPE 4; MKS4	0.00280112	0.276166764453053
ATELOSTEOGENESIS, TYPE I; AO1	0.00280112	0.276166764453053
TROCHLEA OF THE HUMERUS, APLASIA OF	0.00280112	0.276166764453053
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.00280112	0.276166764453053
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.00280112	0.276166764453053
RETINOBLASTOMA; RB1	0.00280112	0.276166764453053
#613091 ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	0.00280112	0.276166764453053
DIAMOND-BLACKFAN ANEMIA 10	0.00280112	0.276166764453053
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.00280112	0.276166764453053
OCULOPALATOCEREBRAL SYNDROME	0.00280112	0.276166764453053
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.00280112	0.276166764453053
VAN DER WOUDE SYNDROME	0.00280112	0.276166764453053
CLEFT PALATE-LATERAL SYNECHIA SYNDROME	0.00280112	0.276166764453053
LOWRY-MACLEAN SYNDROME	0.00280112	0.276166764453053
HOLZGREVE SYNDROME	0.00280112	0.276166764453053
HEMIFACIAL MICROSOMIA	0.00280112	0.276166764453053
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.00280112	0.276166764453053
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.00280112	0.276166764453053
#108721 ATELOSTEOGENESIS, TYPE III; AOIII;;AO3	0.00280112	0.276166764453053
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.00280112	0.276166764453053
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.00280112	0.276166764453053
#246560 SPLIT-HAND/FOOT MALFORMATION 3; SHFM3;;SHSF3;;LIMB DEFICIENCIES, DISTAL, WITH MICROGNATHIA;;CHROMOSOME 10Q24 DUPLICATION SYNDROME	0.00280112	0.276166764453053
#156550 KNIEST DYSPLASIA	0.00280112	0.276166764453053
%119530 OROFACIAL CLEFT 1; OFC1;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 1;;OROFACIAL CLEFT, NONSYNDROMIC; OFC;;CLEFT LIP/PALATE, NONSYNDROMIC	0.00280112	0.276166764453053
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B; CPSKF1B	0.00280112	0.276166764453053
FIBROCHONDROGENESIS 1; FBCG1	0.00280112	0.276166764453053
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.00280112	0.276166764453053
STICKLER SYNDROME, TYPE III	0.00280112	0.276166764453053
MEGAEPIPHYSEAL DWARFISM	0.00280112	0.276166764453053
PIERRE ROBIN SYNDROME	0.00280112	0.276166764453053
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.00280112	0.276166764453053
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.00280112	0.276166764453053
#200610 ACHONDROGENESIS, TYPE II; ACG2;;ACHONDROGENESIS, LANGER-SALDINO TYPE;;CHONDROGENESIS IMPERFECTA;;ACHONDROGENESIS, TYPE IB, FORMERLYHYPOCHONDROGENESIS, INCLUDED	0.00280112	0.276166764453053
AICARDI SYNDROME; AIC	0.00280112	0.276166764453053
OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL	0.00280112	0.276166764453053
#603194 MECKEL SYNDROME, TYPE 2; MKS2;;MECKEL-GRUBER SYNDROME, TYPE 2	0.00280112	0.276166764453053
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.00280112	0.276166764453053
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00280112	0.276166764453053
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.00280112	0.276166764453053
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.00280112	0.276166764453053
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00280112	0.276166764453053
PARIETAL FORAMINA	0.00280112	0.276166764453053
#603543 LIMB-MAMMARY SYNDROME; LMS	0.00280112	0.276166764453053
CULLER-JONES SYNDROME; CJS	0.00280112	0.276166764453053
MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3	0.00280112	0.276166764453053
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.00280112	0.276166764453053
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00280112	0.276166764453053
OCULODENTODIGITAL DYSPLASIA; ODDD	0.00280112	0.276166764453053
FOCAL DERMAL HYPOPLASIA; FDH	0.00280112	0.276166764453053
OROFACIODIGITAL SYNDROME XI; OFD11	0.00280112	0.276166764453053
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.00280112	0.276166764453053
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.00280112	0.276166764453053
GENITOPALATOCARDIAC SYNDROME	0.00280112	0.276166764453053
HYPOTHYROIDISM, ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE	0.00280112	0.276166764453053
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00280112	0.276166764453053
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.00280112	0.276166764453053
ANKYLOBLEPHARON FILIFORME ADNATUM AND CLEFT PALATE	0.00280112	0.276166764453053
2q33.1 deletion syndrome	0.00280112	0.276166764453053
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00280112	0.276166764453053
#613885 MECKEL SYNDROME, TYPE 8; MKS8	0.00280112	0.276166764453053
KAPUR-TORIELLO SYNDROME	0.00280112	0.276166764453053
PIERRE ROBIN SYNDROME AND OLIGODACTYLY	0.00280112	0.276166764453053
OROFACIODIGITAL SYNDROME X	0.00280112	0.276166764453053
CATEL-MANZKE SYNDROME; CATMANS	0.00280112	0.276166764453053
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00280112	0.276166764453053
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00280112	0.276166764453053
ADDUCTED THUMBS SYNDROME	0.00280112	0.276166764453053
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.00280112	0.276166764453053
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.00280112	0.276166764453053
ROSSELLI-GULIENETTI SYNDROME	0.00280112	0.276166764453053
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.00280112	0.276166764453053
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00280112	0.276166764453053
STICKLER SYNDROME, TYPE I	0.00280112	0.276166764453053
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.00280112	0.276166764453053
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.00280112	0.276166764453053
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00280112	0.276166764453053
KYPHOMELIC DYSPLASIA	0.00280112	0.276166764453053
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00280112	0.276166764453053
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.00280112	0.276166764453053
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.00280112	0.276166764453053
CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	0.00280112	0.276166764453053
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.0027933000000000003	0.2753957785267011
#610542 MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 1; CMSTA1	0.0027933000000000003	0.2753957785267011
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.0027933000000000003	0.2753957785267011
#615629 DEAFNESS, AUTOSOMAL DOMINANT 56; DFNA56	0.0027933000000000003	0.2753957785267011
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT	0.0027933000000000003	0.2753957785267011
DEAFNESS, AUTOSOMAL RECESSIVE 29	0.0027933000000000003	0.2753957785267011
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.0027933000000000003	0.2753957785267011
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.0027933000000000003	0.2753957785267011
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.2753957785267011
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.0027933000000000003	0.2753957785267011
#253010 MUCOPOLYSACCHARIDOSIS TYPE IVB;;MORQUIO SYNDROME B;;MPS IVB; MPS4B	0.0027933000000000003	0.2753957785267011
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0027933000000000003	0.2753957785267011
PAGET DISEASE OF BONE 4; PDB4	0.0027933000000000003	0.2753957785267011
OSTEOGENESIS IMPERFECTA, TYPE I	0.0027933000000000003	0.2753957785267011
KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	0.0027933000000000003	0.2753957785267011
#188025 THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT;;CHROMOSOME 11q23 DELETION SYNDROME	0.0027933000000000003	0.2753957785267011
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.0027933000000000003	0.2753957785267011
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.0027933000000000003	0.2753957785267011
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.0027933000000000003	0.2753957785267011
#254300 MYASTHENIA, LIMB-GIRDLE, FAMILIAL;;LGM;;CONGENITAL MYASTHENIC SYNDROME TYPE Ib; CMS1B;;CMS Ib;;MYASTHENIC MYOPATHY, FORMERLY	0.0027933000000000003	0.2753957785267011
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.0027933000000000003	0.2753957785267011
#614899 DEAFNESS, AUTOSOMAL RECESSIVE 93; DFNB93	0.0027933000000000003	0.2753957785267011
DEAFNESS, X-LINKED 5; DFNX5	0.0027933000000000003	0.2753957785267011
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.0027933000000000003	0.2753957785267011
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0027933000000000003	0.2753957785267011
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.0027933000000000003	0.2753957785267011
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.0027933000000000003	0.2753957785267011
BRITTLE CORNEA SYNDROME 2; BCS2	0.0027933000000000003	0.2753957785267011
JOUBERT SYNDROME 7	0.0027933000000000003	0.2753957785267011
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.0027933000000000003	0.2753957785267011
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.0027933000000000003	0.2753957785267011
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.0027933000000000003	0.2753957785267011
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.0027933000000000003	0.2753957785267011
CAMURATI-ENGELMANN DISEASE	0.0027933000000000003	0.2753957785267011
COXOAURICULAR SYNDROME	0.0027933000000000003	0.2753957785267011
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0027933000000000003	0.2753957785267011
DEAFNESS, AUTOSOMAL RECESSIVE 55	0.0027933000000000003	0.2753957785267011
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.0027933000000000003	0.2753957785267011
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.0027933000000000003	0.2753957785267011
MENIERE DISEASE	0.0027933000000000003	0.2753957785267011
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0027933000000000003	0.2753957785267011
PURPURA SIMPLEX	0.0027933000000000003	0.2753957785267011
#258450 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL RECESSIVE; PEOB;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.2753957785267011
NEUROFIBROMATOSIS, TYPE II	0.0027933000000000003	0.2753957785267011
609612 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE;;CONGENITAL FIBROSIS SYNDROME WITH SYNERGISTIC DIVERGENCE;;EXTERNAL OPHTHALMOPLEGIA WITH SYNERGISTIC DIVERGENCEEXTERNAL OPHTHALMOPLEGIA, SYNERGISTIC DIVERGENCE, JAW WINKING, ANDOCULOCUTANEOUS HYPOPIGMENTATION, INCLUDED	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.0027933000000000003	0.2753957785267011
#601462 MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL; SCCMS;;MYASTHENIC SYNDROME, CONGENITAL, POSTSYNAPTIC SLOW-CHANNEL;;MYASTHENIC SYNDROME, CONGENITAL, TYPE IIa; CMS2A;;CMS IIa	0.0027933000000000003	0.2753957785267011
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.0027933000000000003	0.2753957785267011
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.0027933000000000003	0.2753957785267011
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.0027933000000000003	0.2753957785267011
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.0027933000000000003	0.2753957785267011
#614896 SINOATRIAL NODE DYSFUNCTION AND DEAFNESS; SANDD	0.0027933000000000003	0.2753957785267011
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.0027933000000000003	0.2753957785267011
MEIER-GORLIN SYNDROME 8; MGORS8	0.0027933000000000003	0.2753957785267011
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.0027933000000000003	0.2753957785267011
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0027933000000000003	0.2753957785267011
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.0027933000000000003	0.2753957785267011
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0027933000000000003	0.2753957785267011
MACHADO-JOSEPH DISEASE; MJD	0.0027933000000000003	0.2753957785267011
COWDEN SYNDROME 5; CWS5	0.0027933000000000003	0.2753957785267011
%615649 DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54	0.0027933000000000003	0.2753957785267011
DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OFFINGERS AND TOES	0.0027933000000000003	0.2753957785267011
#610896 BRANCHIOOTORENAL SYNDROME 2; BOR2	0.0027933000000000003	0.2753957785267011
DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106	0.0027933000000000003	0.2753957785267011
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.0027933000000000003	0.2753957785267011
HURLER SYNDROME	0.0027933000000000003	0.2753957785267011
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.0027933000000000003	0.2753957785267011
#614504 USHER SYNDROME, TYPE IIIB; USH3B	0.0027933000000000003	0.2753957785267011
#602459 DEAFNESS, AUTOSOMAL DOMINANT 15; DFNA15	0.0027933000000000003	0.2753957785267011
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.0027933000000000003	0.2753957785267011
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.0027933000000000003	0.2753957785267011
%614617 DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	0.0027933000000000003	0.2753957785267011
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.0027933000000000003	0.2753957785267011
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.0027933000000000003	0.2753957785267011
LEIGH SYNDROME; LS	0.0027933000000000003	0.2753957785267011
%607683 DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52;;DEAFNESS, AUTOSOMAL DOMINANT 42; DFNA42	0.0027933000000000003	0.2753957785267011
#601455 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, LOM TYPE; HMSNL;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE4D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4D;;HMSN4D	0.0027933000000000003	0.2753957785267011
OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA	0.0027933000000000003	0.2753957785267011
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.0027933000000000003	0.2753957785267011
DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65	0.0027933000000000003	0.2753957785267011
WILDERVANCK SYNDROME	0.0027933000000000003	0.2753957785267011
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.2753957785267011
USHER SYNDROME, TYPE IID; USH2D	0.0027933000000000003	0.2753957785267011
CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS	0.0027933000000000003	0.2753957785267011
MYASTHENIA GRAVIS; MG	0.0027933000000000003	0.2753957785267011
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.0027933000000000003	0.2753957785267011
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.0027933000000000003	0.2753957785267011
DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107	0.0027933000000000003	0.2753957785267011
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.0027933000000000003	0.2753957785267011
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0027933000000000003	0.2753957785267011
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.0027933000000000003	0.2753957785267011
GLYCOGEN STORAGE DISEASE II	0.0027933000000000003	0.2753957785267011
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.0027933000000000003	0.2753957785267011
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.0027933000000000003	0.2753957785267011
REFSUM DISEASE	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.0027933000000000003	0.2753957785267011
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.0027933000000000003	0.2753957785267011
#612645 DEAFNESS, AUTOSOMAL RECESSIVE 1B; DFNB1B	0.0027933000000000003	0.2753957785267011
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.0027933000000000003	0.2753957785267011
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.0027933000000000003	0.2753957785267011
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.0027933000000000003	0.2753957785267011
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 5; CFEOM5	0.0027933000000000003	0.2753957785267011
IVIC SYNDROME	0.0027933000000000003	0.2753957785267011
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.0027933000000000003	0.2753957785267011
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0027933000000000003	0.2753957785267011
HUNTER-MACDONALD SYNDROME	0.0027933000000000003	0.2753957785267011
AUROCEPHALOSYNDACTYLY	0.0027933000000000003	0.2753957785267011
#610246 SPINOCEREBELLAR ATAXIA 28; SCA28	0.0027933000000000003	0.2753957785267011
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.0027933000000000003	0.2753957785267011
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.0027933000000000003	0.2753957785267011
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.0027933000000000003	0.2753957785267011
FANCONI ANEMIA	0.0027933000000000003	0.2753957785267011
DEAFNESS, AUTOSOMAL RECESSIVE 33	0.0027933000000000003	0.2753957785267011
%613916 DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	0.0027933000000000003	0.2753957785267011
#614614 DEAFNESS, AUTOSOMAL DOMINANT 4B; DFNA4B	0.0027933000000000003	0.2753957785267011
NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS	0.0027933000000000003	0.2753957785267011
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.0027933000000000003	0.2753957785267011
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.0027933000000000003	0.2753957785267011
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.0027933000000000003	0.2753957785267011
OSTEOGENESIS IMPERFECTA, TYPE IV	0.0027933000000000003	0.2753957785267011
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0027933000000000003	0.2753957785267011
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.0027933000000000003	0.2753957785267011
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.0027933000000000003	0.2753957785267011
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.0027933000000000003	0.2753957785267011
#613558 DEAFNESS, AUTOSOMAL DOMINANT 51; DFNA51;;CHROMOSOME 9Q21.11 DUPLICATION SYNDROME	0.0027933000000000003	0.2753957785267011
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.0027933000000000003	0.2753957785267011
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.0027933000000000003	0.2753957785267011
PEROXISOME BIOGENESIS DISORDER 11B	0.0027933000000000003	0.2753957785267011
WARBURG MICRO SYNDROME 1	0.0027933000000000003	0.2753957785267011
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.0027933000000000003	0.2753957785267011
HYDROXYKYNURENINURIA	0.0027933000000000003	0.2753957785267011
DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.0027933000000000003	0.2753957785267011
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.0027933000000000003	0.2753957785267011
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.0027933000000000003	0.2753957785267011
COWDEN SYNDROME 6; CWS6	0.0027933000000000003	0.2753957785267011
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.0027933000000000003	0.2753957785267011
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.0027933000000000003	0.2753957785267011
%614414 DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96	0.0027933000000000003	0.2753957785267011
LISSENCEPHALY 5; LIS5	0.0027933000000000003	0.2753957785267011
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.0027933000000000003	0.2753957785267011
#615429 DEAFNESS, AUTOSOMAL RECESSIVE 88; DFNB88	0.0027933000000000003	0.2753957785267011
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.0027933000000000003	0.2753957785267011
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0027933000000000003	0.2753957785267011
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.0027933000000000003	0.2753957785267011
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.0027933000000000003	0.2753957785267011
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.0027933000000000003	0.2753957785267011
#255320 MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MINICORE MYOPATHY;;MULTICORE MYOPATHY;;MULTIMINICORE MYOPATHY MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MULTIMINICORE DISEASE WITH EXTERNAL OPHTHALMOPLEGIA	0.0027933000000000003	0.2753957785267011
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0027933000000000003	0.2753957785267011
KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	0.0027933000000000003	0.2753957785267011
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.0027933000000000003	0.2753957785267011
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 9, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS9	0.0027933000000000003	0.2753957785267011
COFFIN-SIRIS SYNDROME 3; CSS3	0.0027933000000000003	0.2753957785267011
CODAS SYNDROME	0.0027933000000000003	0.2753957785267011
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.0027933000000000003	0.2753957785267011
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.0027933000000000003	0.2753957785267011
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	0.0027933000000000003	0.2753957785267011
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.0027933000000000003	0.2753957785267011
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.0027933000000000003	0.2753957785267011
JOUBERT SYNDROME 21	0.0027933000000000003	0.2753957785267011
DEMENTIA, FAMILIAL DANISH	0.0027933000000000003	0.2753957785267011
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.0027933000000000003	0.2753957785267011
#300914 DEAFNESS, X-LINKED 6; DFNX6	0.0027933000000000003	0.2753957785267011
XYLOSIDASE DEFICIENCY	0.0027933000000000003	0.2753957785267011
%615654 DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58	0.0027933000000000003	0.2753957785267011
WIDOW&#39;S PEAK SYNDROME	0.0027933000000000003	0.2753957785267011
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0027933000000000003	0.2753957785267011
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.0027933000000000003	0.2753957785267011
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0027933000000000003	0.2753957785267011
DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0027933000000000003	0.2753957785267011
DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74	0.0027933000000000003	0.2753957785267011
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.0027933000000000003	0.2753957785267011
VISUAL IMPAIRMENT AND PROGRESSIVE PHTHISIS BULBI; VIPB	0.0027933000000000003	0.2753957785267011
DEAFNESS, AUTOSOMAL RECESSIVE 47	0.0027933000000000003	0.2753957785267011
#613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	0.0027933000000000003	0.2753957785267011
RAMON SYNDROME	0.0027933000000000003	0.2753957785267011
#614934 DEAFNESS, AUTOSOMAL RECESSIVE 70; DFNB70	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0027933000000000003	0.2753957785267011
RHYNS SYNDROME; RHYNS	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0027933000000000003	0.2753957785267011
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.0027933000000000003	0.2753957785267011
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.0027933000000000003	0.2753957785267011
#614944 DEAFNESS, AUTOSOMAL RECESSIVE 84B; DFNB84B	0.0027933000000000003	0.2753957785267011
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.0027933000000000003	0.2753957785267011
ANUS, IMPERFORATE	0.0027933000000000003	0.2753957785267011
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.0027933000000000003	0.2753957785267011
WERNICKE-KORSAKOFF SYNDROME	0.0027933000000000003	0.2753957785267011
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.0027933000000000003	0.2753957785267011
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.0027933000000000003	0.2753957785267011
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.0027933000000000003	0.2753957785267011
FACIOCARDIOMELIC SYNDROME	0.0027933000000000003	0.2753957785267011
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.0027933000000000003	0.2753957785267011
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0027933000000000003	0.2753957785267011
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.0027933000000000003	0.2753957785267011
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.0027933000000000003	0.2753957785267011
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.0027933000000000003	0.2753957785267011
HOLOPROSENCEPHALY 4	0.0027933000000000003	0.2753957785267011
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.0027933000000000003	0.2753957785267011
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.0027933000000000003	0.2753957785267011
COFFIN-SIRIS SYNDROME 4; CSS4	0.0027933000000000003	0.2753957785267011
BRITTLE CORNEA SYNDROME	0.0027933000000000003	0.2753957785267011
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.0027933000000000003	0.2753957785267011
BULBAR PALSY, PROGRESSIVE, OF CHILDHOOD	0.0027933000000000003	0.2753957785267011
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.0027933000000000003	0.2753957785267011
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.0027933000000000003	0.2753957785267011
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.0027933000000000003	0.2753957785267011
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.0027933000000000003	0.2753957785267011
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.0027933000000000003	0.2753957785267011
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.0027933000000000003	0.2753957785267011
ARIMA SYNDROME	0.0027933000000000003	0.2753957785267011
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.0027933000000000003	0.2753957785267011
184705 STEINFELD SYNDROME	0.0027933000000000003	0.2753957785267011
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.0027933000000000003	0.2753957785267011
EAR EXOSTOSES	0.0027933000000000003	0.2753957785267011
N SYNDROME	0.0027933000000000003	0.2753957785267011
OPHTHALMOPLEGIA, FAMILIAL STATIC	0.0027933000000000003	0.2753957785267011
SPINOCEREBELLAR ATAXIA 13	0.0027933000000000003	0.2753957785267011
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.0027933000000000003	0.2753957785267011
#615156 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL DOMINANT, 6; PEOA6;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT, 6	0.0027933000000000003	0.2753957785267011
SALIH MYOPATHY; SALMY	0.0027933000000000003	0.2753957785267011
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.0027933000000000003	0.2753957785267011
DEAFNESS, AUTOSOMAL DOMINANT 24	0.0027933000000000003	0.2753957785267011
#255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;;MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.2753957785267011
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.0027933000000000003	0.2753957785267011
RETINAL VENOUS BEADING	0.0027933000000000003	0.2753957785267011
USHER SYNDROME, TYPE ID	0.0027933000000000003	0.2753957785267011
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0027933000000000003	0.2753957785267011
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.0027933000000000003	0.2753957785267011
%300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	0.0027933000000000003	0.2753957785267011
WARSAW BREAKAGE SYNDROME; WABS	0.0027933000000000003	0.2753957785267011
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.0027933000000000003	0.2753957785267011
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.0027933000000000003	0.2753957785267011
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.0027933000000000003	0.2753957785267011
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0027933000000000003	0.2753957785267011
BRANCHIOOTIC SYNDROME 2	0.0027933000000000003	0.2753957785267011
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.0027933000000000003	0.2753957785267011
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.0027933000000000003	0.2753957785267011
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.0027933000000000003	0.2753957785267011
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.0027933000000000003	0.2753957785267011
PAGET DISEASE OF BONE 3; PDB3	0.0027933000000000003	0.2753957785267011
OTOSCLEROSIS 8; OTSC8	0.0027933000000000003	0.2753957785267011
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 2	0.0027933000000000003	0.2753957785267011
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0027933000000000003	0.2753957785267011
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.0027933000000000003	0.2753957785267011
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.0027933000000000003	0.2753957785267011
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.0027933000000000003	0.2753957785267011
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.0027933000000000003	0.2753957785267011
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.0027933000000000003	0.2753957785267011
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.0027933000000000003	0.2753957785267011
TUKEL SYNDROME	0.0027933000000000003	0.2753957785267011
#174800 MCCUNE-ALBRIGHT SYNDROME; MAS;;ALBRIGHT SYNDROMEPOLYOSTOTIC FIBROUS DYSPLASIA, INCLUDED; PFD, INCLUDED; POFD, INCLUDED	0.0027933000000000003	0.2753957785267011
TUNE DEAFNESS	0.0027933000000000003	0.2753957785267011
#600971 DEAFNESS, AUTOSOMAL RECESSIVE 6; DFNB6;;NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 6; NSRD6	0.0027933000000000003	0.2753957785267011
ABCD SYNDROME	0.0027933000000000003	0.2753957785267011
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.0027933000000000003	0.2753957785267011
FRONTOOCULAR SYNDROME	0.0027933000000000003	0.2753957785267011
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.0027933000000000003	0.2753957785267011
JOUBERT SYNDROME 35; JBTS35	0.0027933000000000003	0.2753957785267011
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.0027933000000000003	0.2753957785267011
INFANTILE SIALIC ACID STORAGE DISEASE	0.0027933000000000003	0.2753957785267011
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 13	0.0027933000000000003	0.2753957785267011
KEARNS-SAYRE SYNDROME; KSS	0.0027933000000000003	0.2753957785267011
#158901 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2; FSHD2;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2, DIGENIC;;FSHD2, DIGENIC;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 2;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1B; FSHD1B	0.0027933000000000003	0.2753957785267011
#239100 HYPEROSTOSIS CORTICALIS GENERALISATA;;VAN BUCHEM DISEASE; VBCH;;HYPERPHOSPHATASEMIA TARDA;;ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.2753957785267011
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.0027933000000000003	0.2753957785267011
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.0027933000000000003	0.2753957785267011
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.0027933000000000003	0.2753957785267011
DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73	0.0027933000000000003	0.2753957785267011
PULMONIC STENOSIS AND DEAFNESS	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0027933000000000003	0.2753957785267011
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.0027933000000000003	0.2753957785267011
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.0027933000000000003	0.2753957785267011
LYMPHEDEMA, HEREDITARY, III	0.0027933000000000003	0.2753957785267011
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.0027933000000000003	0.2753957785267011
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.0027933000000000003	0.2753957785267011
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.0027933000000000003	0.2753957785267011
NATHALIE SYNDROME	0.0027933000000000003	0.2753957785267011
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.0027933000000000003	0.2753957785267011
CHIARI MALFORMATION TYPE I	0.0027933000000000003	0.2753957785267011
OTOSCLEROSIS 3; OTSC3	0.0027933000000000003	0.2753957785267011
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0027933000000000003	0.2753957785267011
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.0027933000000000003	0.2753957785267011
CONE-ROD DYSTROPHY 1; CORD1	0.0027933000000000003	0.2753957785267011
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.0027933000000000003	0.2753957785267011
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0027933000000000003	0.2753957785267011
#613718 DEAFNESS, AUTOSOMAL RECESSIVE 74; DFNB74	0.0027933000000000003	0.2753957785267011
121450 CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS;;BAND KERATOPATHY WITH DEAFNESS	0.0027933000000000003	0.2753957785267011
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.0027933000000000003	0.2753957785267011
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0027933000000000003	0.2753957785267011
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0027933000000000003	0.2753957785267011
KEUTEL SYNDROME; KTLS	0.0027933000000000003	0.2753957785267011
SPASTIC PARAPARESIS AND DEAFNESS	0.0027933000000000003	0.2753957785267011
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.0027933000000000003	0.2753957785267011
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0027933000000000003	0.2753957785267011
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0027933000000000003	0.2753957785267011
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0027933000000000003	0.2753957785267011
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.0027933000000000003	0.2753957785267011
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.0027933000000000003	0.2753957785267011
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.0027933000000000003	0.2753957785267011
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.0027933000000000003	0.2753957785267011
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.0027933000000000003	0.2753957785267011
MORQUIO SYNDROME A	0.0027933000000000003	0.2753957785267011
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.0027933000000000003	0.2753957785267011
HYPOTONIA-CYSTINURIA SYNDROME	0.0027933000000000003	0.2753957785267011
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.0027933000000000003	0.2753957785267011
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.2753957785267011
%300245 PTOSIS, HEREDITARY CONGENITAL 2;;PTOS2;;PTOSIS, X-LINKED; PTOSX	0.0027933000000000003	0.2753957785267011
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.0027933000000000003	0.2753957785267011
FETAL IODINE DEFICIENCY DISORDER	0.0027933000000000003	0.2753957785267011
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.0027933000000000003	0.2753957785267011
DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	0.0027933000000000003	0.2753957785267011
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.0027933000000000003	0.2753957785267011
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.0027933000000000003	0.2753957785267011
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.0027933000000000003	0.2753957785267011
RENAL, GENITAL, AND MIDDLE EAR ANOMALIES	0.0027933000000000003	0.2753957785267011
CLUSTER HEADACHE, FAMILIAL	0.0027933000000000003	0.2753957785267011
#606763 CILIARY DYSKINESIA, PRIMARY, 2; CILD2;;CILIARY DYSKINESIA, PRIMARY, 2, WITH OR WITHOUT SITUS INVERSUS	0.0027933000000000003	0.2753957785267011
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.0027933000000000003	0.2753957785267011
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00185874	0.1832560589190994
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00185874	0.1832560589190994
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.00185874	0.1832560589190994
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.00185874	0.1832560589190994
KBG SYNDROME	0.00185874	0.1832560589190994
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.00185874	0.1832560589190994
JOUBERT SYNDROME 2	0.00185874	0.1832560589190994
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.00185874	0.1832560589190994
OPSISMODYSPLASIA; OPSMD	0.00185874	0.1832560589190994
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00185874	0.1832560589190994
ADAMS-OLIVER SYNDROME 2; AOS2	0.00185874	0.1832560589190994
NEUROFIBROMATOSIS, TYPE I	0.00185874	0.1832560589190994
CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA	0.00185874	0.1832560589190994
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.00185874	0.1832560589190994
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.00185874	0.1832560589190994
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00185874	0.1832560589190994
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00185874	0.1832560589190994
RESTRICTIVE DERMOPATHY, LETHAL	0.00185874	0.1832560589190994
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.00185874	0.1832560589190994
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.00185874	0.1832560589190994
GASTROCUTANEOUS SYNDROME	0.00185874	0.1832560589190994
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.00185874	0.1832560589190994
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00185874	0.1832560589190994
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00185874	0.1832560589190994
#217095 CONOTRUNCAL HEART MALFORMATIONS; CTHMTRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED;;INTERRUPTED AORTIC ARCH, INCLUDED	0.00185874	0.1832560589190994
#614485 TRIGONOCEPHALY 2; TRIGNO2;;CRANIOSYNOSTOSIS, METOPIC	0.00185874	0.1832560589190994
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.00185874	0.1832560589190994
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.00185874	0.1832560589190994
GLYCEROL KINASE DEFICIENCY; GKD	0.00185874	0.1832560589190994
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.00185874	0.1832560589190994
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.00185874	0.1832560589190994
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.00185874	0.1832560589190994
OROFACIODIGITAL SYNDROME III	0.00185874	0.1832560589190994
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00185874	0.1832560589190994
HOLOPROSENCEPHALY 5; HPE5	0.00185874	0.1832560589190994
NASODIGITOACOUSTIC SYNDROME	0.00185874	0.1832560589190994
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00185874	0.1832560589190994
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.00185874	0.1832560589190994
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.00185874	0.1832560589190994
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.00185874	0.1832560589190994
#602482 AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3;;AXENFELD-RIEGER ANOMALY WITH OR WITHOUT CARDIAC DEFECTS AND/OR SENSORINEURALHEARING LOSS;;ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS;;ANTERIOR CHAMBER CLEAVAGE SYNDROME;;RIEGER SYNDROME, TYPE 3AXENFELD ANOMALY, INCLUDED;;RIEGER ANOMALY, INCLUDED;;AXENFELD-RIEGER ANOMALY, INCLUDED	0.00185874	0.1832560589190994
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00185874	0.1832560589190994
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.00185874	0.1832560589190994
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.00185874	0.1832560589190994
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.00185874	0.1832560589190994
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.00185874	0.1832560589190994
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.00185874	0.1832560589190994
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.00185874	0.1832560589190994
#614195 CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS	0.00185874	0.1832560589190994
DUANE-RADIAL RAY SYNDROME; DRRS	0.00185874	0.1832560589190994
ROBINOW-SORAUF SYNDROME	0.00185874	0.1832560589190994
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00185874	0.1832560589190994
#604173 POIKILODERMA WITH NEUTROPENIA; PN;;POIKILODERMA WITH NEUTROPENIA, CLERICUZIO-TYPE	0.00185874	0.1832560589190994
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.00185874	0.1832560589190994
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.00185874	0.1832560589190994
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00185874	0.1832560589190994
CRANIOSYNOSTOSIS 4; CRS4	0.00185874	0.1832560589190994
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00185874	0.1832560589190994
LAMBOTTE SYNDROME	0.00185874	0.1832560589190994
#191830 RENAL HYPODYSPLASIA/APLASIA 1; RHDA1;;RENAL ADYSPLASIA;;RENAL AGENESIS;;RENAL APLASIA;;HEREDITARY RENAL APLASIA; HRA	0.00185874	0.1832560589190994
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.00185874	0.1832560589190994
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.00185874	0.1832560589190994
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00185874	0.1832560589190994
JOUBERT SYNDROME 32; JBTS32	0.00185874	0.1832560589190994
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00185874	0.1832560589190994
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00185874	0.1832560589190994
#613506 AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5;;AGAMMAGLOBULINEMIA, AUTOSOMAL DOMINANT, DUE TO LRRC8A DEFECT	0.00185874	0.1832560589190994
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00185874	0.1832560589190994
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.00185874	0.1832560589190994
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.00185874	0.1832560589190994
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.00185874	0.1832560589190994
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00185874	0.1832560589190994
CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	0.00185874	0.1832560589190994
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00185874	0.1832560589190994
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.00185874	0.1832560589190994
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.00185874	0.1832560589190994
SCHIZOPHRENIA 1; SCZD1	0.00185874	0.1832560589190994
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00185874	0.1832560589190994
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.00185874	0.1832560589190994
WHITE FORELOCK WITH MALFORMATIONS	0.00185874	0.1832560589190994
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.00185874	0.1832560589190994
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00185874	0.1832560589190994
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.00185874	0.1832560589190994
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.00185874	0.1832560589190994
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.00185874	0.1832560589190994
KEIPERT SYNDROME; KPTS	0.00185874	0.1832560589190994
BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	0.00185874	0.1832560589190994
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	0.00185874	0.1832560589190994
#609597 PARIETAL FORAMINA 2; PFM2	0.00185874	0.1832560589190994
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.00185874	0.1832560589190994
TEMPLE-BARAITSER SYNDROME; TMBTS	0.00185874	0.1832560589190994
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00185874	0.1832560589190994
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.00185874	0.1832560589190994
MANITOBA OCULOTRICHOANAL SYNDROME	0.00185874	0.1832560589190994
CROUZON SYNDROME	0.00185874	0.1832560589190994
CHROMOSOME 4q21 DELETION SYNDROME	0.00185874	0.1832560589190994
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.00185874	0.1832560589190994
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.00185874	0.1832560589190994
WIDOW'S PEAK	0.00185874	0.1832560589190994
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.00185874	0.1832560589190994
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.00185874	0.1832560589190994
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.00185874	0.1832560589190994
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.00185874	0.1832560589190994
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00185874	0.1832560589190994
MENTAL RETARDATION, X-LINKED 106; MRX106	0.00185874	0.1832560589190994
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.00185874	0.1832560589190994
#614185 GELEOPHYSIC DYSPLASIA 2; GPHYSD2	0.00185874	0.1832560589190994
NF1-microdeletion syndrome	0.00185874	0.1832560589190994
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.00185874	0.1832560589190994
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.00185874	0.1832560589190994
PACHYGYRIA, FRONTOTEMPORAL	0.00185874	0.1832560589190994
#607095 ANAUXETIC DYSPLASIA;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, ANAUXETIC TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA, MENGER TYPE	0.00185874	0.1832560589190994
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00185874	0.1832560589190994
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.00185874	0.1832560589190994
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00185874	0.1832560589190994
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.00185874	0.1832560589190994
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.00185874	0.1832560589190994
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.00185874	0.1832560589190994
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.00185874	0.1832560589190994
OROFACIAL CLEFT 15	0.00185874	0.1832560589190994
DIAMOND-BLACKFAN ANEMIA 5	0.00185874	0.1832560589190994
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00185874	0.1832560589190994
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.00185874	0.1832560589190994
ALAGILLE SYNDROME 1; ALGS1	0.00185874	0.1832560589190994
HYPERTELORISM	0.00185874	0.1832560589190994
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.00185874	0.1832560589190994
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00185874	0.1832560589190994
GAUCHER DISEASE, PERINATAL LETHAL	0.00185874	0.1832560589190994
TRICHOHEPATOENTERIC SYNDROME 2	0.00185874	0.1832560589190994
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00185874	0.1832560589190994
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.00185874	0.1832560589190994
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.00185874	0.1832560589190994
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.00185874	0.1832560589190994
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00185874	0.1832560589190994
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00185874	0.1832560589190994
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00185874	0.1832560589190994
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.00185874	0.1832560589190994
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00185874	0.1832560589190994
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.00185874	0.1832560589190994
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00185874	0.1832560589190994
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.00185874	0.1832560589190994
